MASS GENERAL BRIGHAM INCORPORATED: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- MASS GENERAL BRIGHAM INCORPORATED (EIN 04-2103591)
- Tax period
- 2016-10-01 to 2017-09-30
- Filed
- 2018-08-15
- IRS object ID
- 201802279349301820
- Schema version
- 2016v3.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule H
- Schedule I
- Schedule J
- Schedule K
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-08-15T11:28:27-05:00 | ReturnTs |
| Tax Period End | 2017-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PricewaterhouseCoopers LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 101 SEAPORT BLVD SUITE 500 | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02210 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 042103591 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS EYE & EAR INFIRMARY | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % JACK MALLEY | InCareOfNm |
| Business Name Control | MASS | BusinessNameControlTxt |
| Phone | 6175733942 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02114 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | CAROLANN WILLIAMS | PersonNm |
| Person Title | CFO & VP FIN & ADMIN | PersonTitleTxt |
| Phone | 6175733012 | PhoneNum |
| Signature | 2018-07-17 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | ERIN COUTURE | PreparerPersonNm |
| PTIN | P01390592 | PTIN |
| Phone | 6175305000 | PhoneNum |
| Preparation | 2018-07-31 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CAROLANN WILLIAMS | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02114 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $278,938,745 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.MASSEYEANDEAR.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1827 | FormationYr |
| Legal Domicile State | MA | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O. | ActivityOrMissionDesc |
| Voting Members Governing Body | 18 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 14 | VotingMembersIndependentCnt |
| Total Employee | 2134 | TotalEmployeeCnt |
| Total Volunteers | 213 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $48,376,154 | PYContributionsGrantsAmt |
| CY Contributions Grants | $47,291,002 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $206,825,055 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $226,533,383 | CYProgramServiceRevenueAmt |
| PY Investment Income | $131,842 | PYInvestmentIncomeAmt |
| CY Investment Income | $410,621 | CYInvestmentIncomeAmt |
| PY Other Revenue | $4,784,378 | PYOtherRevenueAmt |
| CY Other Revenue | $4,703,739 | CYOtherRevenueAmt |
| PY Total Revenue | $260,117,429 | PYTotalRevenueAmt |
| CY Total Revenue | $278,938,745 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $19,338,997 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $18,435,862 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $113,508,491 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $117,853,083 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $329,030 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $122,094 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $2,414,612 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $127,477,258 | PYOtherExpensesAmt |
| CY Other Expenses | $139,687,369 | CYOtherExpensesAmt |
| PY Total Expenses | $260,653,776 | PYTotalExpensesAmt |
| CY Total Expenses | $276,098,408 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$536,347 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $2,840,337 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $330,811,290 | TotalAssetsBOYAmt |
| Total Assets EOY | $417,880,268 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $334,042,965 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $410,523,209 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | -$3,231,675 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $7,357,059 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $157,935,601 | ExpenseAmt |
| Grant | $18,309,002 | GrantAmt |
| Revenue | $9,075,728 | RevenueAmt |
| Desc | SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $46,773,125 | ExpenseAmt |
| Grant | $126,860 | GrantAmt |
| Desc | SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $5,529,071 | ExpenseAmt |
| Revenue | $217,457,655 | RevenueAmt |
| Desc | SEE SCHEDULE O | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $210,237,797 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | Yes (true) | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | Yes (true) | OperateHospitalInd |
| Audited Financial Stmt Att | Yes (true) | AuditedFinancialStmtAttInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | Yes (true) | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (true) | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (true) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 161 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 2134 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 18 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 14 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JACK MALLEY | PersonNm |
| Phone | 6175733235 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02114 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (37 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| JOHN R FERNANDEZ | |||||||||
| PRESIDENT | 37.0 | 23.0 | Yes (X) | Yes (X) | $1,015,184 | $0 | $244,873 | ||
| WYCLIFFE GROUSBECK | |||||||||
| CHAIR | 3.0 | 7.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| JONATHAN UHRIG | |||||||||
| TREASURER | 3.0 | 7.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| DEWALT PETE ANKENY | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | $0 | $0 | $0 | |||
| JAMES CARLISLE | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| CHARLES DE GUNZBERG | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | $0 | $0 | $0 | |||
| SAMUEL FLEMING | |||||||||
| DIRECTOR (UNTIL DECEMBER 2016) | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| HARVEY FREISHTAT | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| LYLE HOWLAND | |||||||||
| SECRETARY | 2.0 | 6.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| DIANE E KANEB | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| JONATHAN KUTCHINS | |||||||||
| DIRECTOR | 2.0 | 4.0 | Yes (X) | $0 | $0 | $0 | |||
| JOAN W MILLER MD | |||||||||
| DIRECTOR | 27.0 | 33.0 | Yes (X) | $0 | $842,571 | $51,150 | |||
| ANNETTE NOVA | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | $0 | $0 | $0 | |||
| WILLIAM ROMAN | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| EUGENE HILL | |||||||||
| Director | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT ATCHINSON | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT KNAPP | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| D BRADLEY WELLING | |||||||||
| DIRECTOR | 29.0 | 31.0 | Yes (X) | $0 | $1,006,748 | $59,446 | |||
| THOMAS LAUER | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | |||
| MAUREEN KELLEY | |||||||||
| ASST SECRETARY | 53.0 | 7.0 | Yes (X) | $194,665 | $0 | $28,866 | |||
| CAROLANN WILLIAMS | |||||||||
| CFO & VP FINANCE AND ADMIN | 49.0 | 11.0 | Yes (X) | $471,086 | $0 | $14,925 | |||
| MARTHA PYLE FARRELL | |||||||||
| ASST SECRETARY | 49.0 | 11.0 | Yes (X) | $350,230 | $0 | $34,755 | |||
| BARBARA J SCULLY | |||||||||
| DIRECTOR PROF REV CYCLE | 30.0 | 30.0 | $188,376 | $0 | $38,423 | Yes (X) | |||
| EILEEN O LOWELL | |||||||||
| CNO & VP PAT CARE SVS | 60.0 | 0.0 | $298,953 | $0 | $31,125 | Yes (X) | |||
| ALAN K LONG | |||||||||
| VP RESEARCH ADMINISTRATION | 30.0 | 30.0 | $292,211 | $0 | $8,996 | Yes (X) | |||
| KENNETH HOLMES | |||||||||
| CFO MEEA | 30.0 | 30.0 | $277,993 | $0 | $40,691 | Yes (X) | |||
| JEFFREY J PIKE | |||||||||
| CHIEF OPERATING OFFICER | 60.0 | 0.0 | $360,971 | $0 | $19,348 | Yes (X) | |||
| RALPH T PELOSI | |||||||||
| DIRECTOR FACILITIES PLANNING | 60.0 | 0.0 | $189,447 | $0 | $9,288 | Yes (X) | |||
| DEBRA ROGERS | |||||||||
| VP OPHTHALMOLOGY | 20.0 | 40.0 | $279,954 | $0 | $25,110 | Yes (X) | |||
| RACHEL WASSERSTROM | |||||||||
| VP OTOLARYNGOLOGY | 30.0 | 30.0 | $273,502 | $0 | $33,143 | Yes (X) | |||
| MICHAEL RICCI | |||||||||
| CHIEF INFORMATION OFFICER | 60.0 | 0.0 | $255,422 | $0 | $25,200 | Yes (X) | |||
| SUNIL EAPPEN MD | |||||||||
| CHIEF MEDICAL OFFICER | 31.0 | 29.0 | $0 | $581,852 | $59,447 | Yes (X) | |||
| JENNIFER STREET | |||||||||
| VP COMMUNICATIONS & PLANNING | 60.0 | 0.0 | $362,593 | $0 | $35,693 | Yes (X) | |||
| MELISSA M PAUL | |||||||||
| CHIEF DEVELOPMENT OFFICER | 60.0 | 0.0 | $291,818 | $0 | $42,912 | Yes (X) | |||
| GLENN W BUNTING | |||||||||
| VOICE & SPEECH CLINICAL DIR | 60.0 | 0.0 | $201,753 | $0 | $43,374 | Yes (X) | |||
| DEBORAH L CRONIN-WAELDE | |||||||||
| EXEC DIR AMBULATORY OPERATIONS | 60.0 | 0.0 | $193,840 | $0 | $3,422 | Yes (X) | |||
| LEO J HILL | |||||||||
| DEPUTY CIO | 60.0 | 0.0 | $189,294 | $0 | $3,309 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $5,687,292 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $2,431,171 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $853,496 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 225 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| KPMG LLP | |||||
| DEPT 0579 PO BOX 120579 | DALLAS | TX | 753120579 | CONSULTING | $1,813,528 |
| SEAMAN DICARLO GENERAL CONTRACTORS | |||||
| 9 WHITNEY STREET | HOLLISTON | MA | 01746 | CONTRACTOR | $836,746 |
| SUFFOLK CONSTRUCTION CO INC | |||||
| 65 ALLERTON STREET | BOSTON | MA | 02119 | CONSTRUCTION | $700,000 |
| FISH AND RICHARDSON PC | |||||
| PO BOX 3295 | BOSTON | MA | 02241 | LEGAL | $697,576 |
| ALKU TECHNOLOGIES LLC | |||||
| 200 BRICKSTONE SQUARE SUITE 503 | ANDOVER | MA | 01810 | CONSULTING | $613,027 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 19 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $21,638,375 | RelatedOrganizationsAmt |
| Government Grants | $16,279,348 | GovernmentGrantsAmt |
| All Other Contributions | $9,373,279 | AllOtherContributionsAmt |
| Total Contributions | $47,291,002 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| INPATIENT AND OUTPATIENT | 900099 | $197,564,415 | $197,564,415 |
| CAFETERIA/FOOD SERVICE | 900099 | $1,836,826 | $1,836,826 |
| RESEARCH INDIRECT REVENUE | 900099 | $9,075,728 | $9,075,728 |
| HEARING AID CENTERS | 900099 | $4,931,637 | $4,931,637 |
| KPRO INCOME | 722210 | $3,058,478 | $3,058,478 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $10,066,299 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $10,066,299 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $226,533,383 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $46,982 | TotalRevenueColumnAmt |
| Exclusion | $46,982 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,703,739 | TotalRevenueColumnAmt |
| Exclusion | $4,703,739 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $363,639 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $363,639 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $363,639 | TotalRevenueColumnAmt |
| Exclusion | $363,639 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $278,938,745 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $226,533,383 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $5,114,360 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,309,002 | TotalAmt |
| Program Services | $18,309,002 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $126,860 | TotalAmt |
| Program Services | $126,860 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,774,576 | TotalAmt |
| Program Services | $1,758,321 | ProgramServicesAmt |
| Management And General | $3,016,255 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,342 | TotalAmt |
| Fundraising | $21,342 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $86,974,005 | TotalAmt |
| Program Services | $67,221,065 | ProgramServicesAmt |
| Management And General | $18,311,050 | ManagementAndGeneralAmt |
| Fundraising | $1,441,890 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,741,135 | TotalAmt |
| Program Services | $1,345,228 | ProgramServicesAmt |
| Management And General | $367,097 | ManagementAndGeneralAmt |
| Fundraising | $28,810 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,229,657 | TotalAmt |
| Program Services | $12,733,075 | ProgramServicesAmt |
| Management And General | $3,224,981 | ManagementAndGeneralAmt |
| Fundraising | $271,601 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,112,368 | TotalAmt |
| Program Services | $6,157,662 | ProgramServicesAmt |
| Management And General | $1,824,909 | ManagementAndGeneralAmt |
| Fundraising | $129,797 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,418,281 | TotalAmt |
| Program Services | $99,766 | ProgramServicesAmt |
| Management And General | $2,318,515 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $370,979 | TotalAmt |
| Management And General | $370,979 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $123,000 | TotalAmt |
| Management And General | $123,000 | ManagementAndGeneralAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $122,094 | TotalAmt |
| Fundraising | $122,094 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,046,681 | TotalAmt |
| Program Services | $2,473,859 | ProgramServicesAmt |
| Management And General | $572,822 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,003,222 | TotalAmt |
| Program Services | $20,055 | ProgramServicesAmt |
| Management And General | $983,167 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,820,823 | TotalAmt |
| Program Services | $703,641 | ProgramServicesAmt |
| Management And General | $914,067 | ManagementAndGeneralAmt |
| Fundraising | $203,115 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,371,591 | TotalAmt |
| Program Services | $2,699,132 | ProgramServicesAmt |
| Management And General | $1,671,561 | ManagementAndGeneralAmt |
| Fundraising | $898 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,855,127 | TotalAmt |
| Program Services | $1,085,282 | ProgramServicesAmt |
| Management And General | $10,769,824 | ManagementAndGeneralAmt |
| Fundraising | $21 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $943,374 | TotalAmt |
| Program Services | $615,792 | ProgramServicesAmt |
| Management And General | $264,873 | ManagementAndGeneralAmt |
| Fundraising | $62,709 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $336,574 | TotalAmt |
| Program Services | $212,188 | ProgramServicesAmt |
| Management And General | $118,228 | ManagementAndGeneralAmt |
| Fundraising | $6,158 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,775,756 | TotalAmt |
| Program Services | $2,486,369 | ProgramServicesAmt |
| Management And General | $1,289,387 | ManagementAndGeneralAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,960,803 | TotalAmt |
| Program Services | $14,461,387 | ProgramServicesAmt |
| Management And General | $7,499,416 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,824,599 | TotalAmt |
| Program Services | $90,873 | ProgramServicesAmt |
| Management And General | $1,733,726 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| MEDICAL SUPPLIES | $56,981,167 | $56,389,912 | $591,145 | $110 |
| PHYSICIANS ADMINISTRATION | $6,215,766 | $6,072,361 | $143,113 | $292 |
| SERVICE CONTRACT | $5,856,821 | $3,231,391 | $2,601,689 | $23,741 |
| FOOD | $1,652,426 | $1,328,612 | $319,797 | $4,017 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,130,379 | TotalAmt |
| Program Services | $10,615,964 | ProgramServicesAmt |
| Management And General | $4,416,398 | ManagementAndGeneralAmt |
| Fundraising | $98,017 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $276,098,408 | TotalAmt |
| Program Services | $210,237,797 | ProgramServicesAmt |
| Management And General | $63,445,999 | ManagementAndGeneralAmt |
| Fundraising | $2,414,612 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,194,722 | BOYAmt |
| EOY | $1,507,830 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,429,492 | BOYAmt |
| EOY | $30,816,896 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,047,488 | BOYAmt |
| EOY | $4,835,627 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,002,989 | BOYAmt |
| EOY | $5,161,230 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $409,109,900 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $255,192,930 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $152,903,737 | BOYAmt |
| EOY | $153,916,970 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $133,232,862 | BOYAmt |
| EOY | $221,641,715 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $330,811,290 | BOYAmt |
| EOY | $417,880,268 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $111,343,756 | BOYAmt |
| EOY | $95,705,517 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,260,223 | BOYAmt |
| EOY | $10,891,093 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $118,496,159 | BOYAmt |
| EOY | $124,421,361 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $92,942,827 | BOYAmt |
| EOY | $179,505,238 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $334,042,965 | BOYAmt |
| EOY | $410,523,209 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | -$3,231,675 | BOYAmt |
| EOY | $7,357,059 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | -$3,231,675 | BOYAmt |
| EOY | $7,357,059 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $330,811,290 | BOYAmt |
| EOY | $417,880,268 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $2,840,337 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $3,079,897 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $4,668,500 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Hospital | Yes (X) | HospitalInd |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $39,413,484 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $41,532,901 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $47,770,745 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $48,376,154 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $47,291,002 | CurrentTaxYearAmt |
| Total | $224,384,286 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $39,413,484 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $41,532,901 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $47,770,745 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $48,376,154 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $47,291,002 | CurrentTaxYearAmt |
| Total | $224,384,286 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $0 | SubstantialContributorsTotAmt |
| Public Support Total170 | $224,384,286 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $16,370,797 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $14,057,593 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,644,064 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,866,437 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $4,750,721 | CurrentTaxYearAmt |
| Total | $43,689,612 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $268,073,898 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $953,036,000 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.83702 | PublicSupportCY170Pct |
| Public Support PY170 | 0.79566 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | Yes (true) | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $123,000 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | false | OtherActivitiesInd |
| Total Lobbying Expenditures | $123,000 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE C, PART II-B, LINE 1(I): | FormAndLineReferenceDesc |
| Explanation | DURING FISCAL YEAR 2017, MASS. EYE AND EAR WAS A MEMBER OF CERTAIN TRADE ASSOCIATIONS THAT MAY LOBBY ON ITS BEHALF. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| Collection Used Pub Exhibition | Yes (X) | CollectionUsedPubExhibitionInd |
| Coll Used Scholarly Rsrch | Yes (X) | CollUsedScholarlyRsrchInd |
| Collection Used Preservation | Yes (X) | CollectionUsedPreservationInd |
| Coll Used Loan Or Exch Prog | Yes (X) | CollUsedLoanOrExchProgInd |
| Solicited Assets Sale | false | SolicitedAssetsSaleInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $72,460,656 | BeginningYearBalanceAmt |
| Contributions | $10,372,206 | ContributionsAmt |
| Investment Earnings Or Losses | $4,293,494 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $12,552,747 | OtherExpendituresAmt |
| Administrative Expenses | $1,136,338 | AdministrativeExpensesAmt |
| End Year Balance | $73,437,271 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $72,613,174 | BeginningYearBalanceAmt |
| Contributions | $1,960,347 | ContributionsAmt |
| Investment Earnings Or Losses | $2,728,854 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,796,280 | OtherExpendituresAmt |
| Administrative Expenses | $1,045,439 | AdministrativeExpensesAmt |
| End Year Balance | $72,460,656 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $78,511,651 | BeginningYearBalanceAmt |
| Contributions | $1,229,040 | ContributionsAmt |
| Investment Earnings Or Losses | -$274,466 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $5,028,553 | OtherExpendituresAmt |
| Administrative Expenses | $1,824,498 | AdministrativeExpensesAmt |
| End Year Balance | $72,613,174 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $87,204,661 | BeginningYearBalanceAmt |
| Contributions | $746,394 | ContributionsAmt |
| Investment Earnings Or Losses | $5,114,694 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $12,790,645 | OtherExpendituresAmt |
| Administrative Expenses | $1,763,453 | AdministrativeExpensesAmt |
| End Year Balance | $78,511,651 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $89,724,541 | BeginningYearBalanceAmt |
| Contributions | $2,692,680 | ContributionsAmt |
| Investment Earnings Or Losses | $3,521,682 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $7,238,559 | OtherExpendituresAmt |
| Administrative Expenses | $1,495,683 | AdministrativeExpensesAmt |
| End Year Balance | $87,204,661 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.03660 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.89590 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.06750 | TermEndowmentBalanceEOYPct |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $535,324 | OtherCostOrOtherBasisAmt |
| Book Value | $535,324 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $198,487,044 | OtherCostOrOtherBasisAmt |
| Depreciation | $134,119,782 | DepreciationAmt |
| Book Value | $64,367,262 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $19,258,400 | OtherCostOrOtherBasisAmt |
| Depreciation | $5,209,720 | DepreciationAmt |
| Book Value | $14,048,680 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $179,449,109 | OtherCostOrOtherBasisAmt |
| Depreciation | $115,852,805 | DepreciationAmt |
| Book Value | $63,596,304 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $11,380,023 | OtherCostOrOtherBasisAmt |
| Depreciation | $10,623 | DepreciationAmt |
| Book Value | $11,369,400 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $153,916,970 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (9 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| DUE FROM AFFILIATES | $193,251,619 |
| FUNDS HELD FOR RESEARCH | $477,486 |
| DEBT SERVICE FUND | $6,373,979 |
| SPECIAL CASH & CAPITAL RESERVE | $3,280,353 |
| QLT | $393,676 |
| DEFERRED FINANCING COSTS | $12,986,300 |
| TAX DEFERRED PLAN | $2,310,072 |
| CRICO | $2,567,846 |
| CAPITAL RESERVE | $384 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $221,641,715 | TotalBookValueOtherAssetsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (5 entries)
| DescDesc | AmtAmt |
|---|---|
| DUE TO AFFILIATES | $168,068,669 |
| ESTIMATE 3RD PARTY SETTLEMENT | $4,682,861 |
| PROFESSIONAL LIABILITY RESERVE | $3,105,530 |
| TAX DEFERRED LIABILITY | $2,310,072 |
| MDFA REVENUE BONDS INTR RATE S | $1,338,106 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $179,505,238 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PART III, LINE 4: | THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN THE MEEI SPECIALTIES OF OPHTHALMOLOGY AND OTOLARYNGOLOGY AS WELL AS A FEW ON THE MEDICAL HISTORY OF BOSTON AND MASSACHUSETTS. THE MAJORITY WERE DONATED ORIGINALLY BY MOSES LURIE, MD AND MRS. LUCIEN HOWE (WIFE OF LUCIEN HOWE, MD). A FEW WERE DONATED BY OTHER PHYSICIANS THROUGH THE YEARS. ENDOWMENT FUNDS SET UP BETWEEN MRS. HOWE AND DR. LURIE WERE DESIGNATED FOR THE OCCASIONAL PURCHASE OF RARE BOOKS TO SUPPLEMENT THE ORIGINAL DONATIONS. THE RARE BOOKS ARE AVAILABLE TO THE SCIENTIFIC, MEDICAL AND ACADEMIC COMMUNITY FOR PURPOSES OF RESEARCH AND EDUCATION. |
| SCHEDULE D, PART V, LINE 4: | THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS IS SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE. |
| SCHEDULE D, PART X, LINE 2: | THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2017. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | Specific Services ProvidedSpecificServicesProvidedTxt |
|---|---|---|---|
| Europe (Including Iceland and Greenland) | Grantmaking | $71,264 | |
| North America | Grantmaking | $55,596 | |
| Europe (Including Iceland and Greenland) | Program Services | $34,478 | CONFERENCE |
| East Asia and the Pacific | Program Services | $45,338 | CONFERENCE |
| Middle East and North Africa | Program Services | $1,179 | CONFERENCE |
| North America | Program Services | $8,516 | CONFERENCE |
| South America | Program Services | $9,376 | CONFERENCE |
| South Asia | Program Services | $2,143 | CONFERENCE |
| Sub-Saharan Africa | Program Services | $23,112 | CONFERENCE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Spent | $251,002 | SubtotalSpentAmt |
| Total Spent | $251,002 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $71,264 | CHECK |
| North America | BASIC RESEARCH | $55,596 | CHECK |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 2 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE F, PART I, LINE 2: | SUBRECIPIENT MONITORING POLICY AND PROCEDURES SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE INFIRMARY ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE. RESEARCH ADMINISTRATION ALSO CONDUCTS AN ANNUAL INVENTORY OF INSTITUTIONS TO WHICH RESERACH HAS BEEN SUBAWARDED. A RISK ASSESSMENT MATRIX IS EMPLOYED, ALONG WITH A REVIEW OF THE SUBRECIPIENTS' MOST RECENT A133 AUDIT REPORT, TO DETERMINE TO DETERMINE THE LEVEL OF RISK REGARDING THE SUBRECIPIENTS' ABILITY TO COMPLY WITH FEDERAL GUIDELINES. |
| SCHEDULE F, PART I, LINE 3, COLUMN (F) AND PART II, LINE 1: | THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER. |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)
| ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Retained By ContractorRetainedByContractorAmt |
|---|---|---|
| VISION PHILANTHROPY GROUP | ||
| CAPITAL CAMPAIGN | false | $67,094 |
| HUNTSINGER JEFFER | ||
| ANNUAL FUND | false | $55,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Retained By Contractors | $122,094 | TotalRetainedByContractorsAmt |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE G, PART I, LINE 2B, COLUMN (V): | FormAndLineReferenceDesc |
| Explanation | DURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2017, MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH HUNTSINGER & JEFFER, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PATIENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN. HUNTSINGER & JEFFER 809 BROOK HILL CIRCLE RICHMOND, VA 23227 VISION PHILANTHROPY GROUP 401 BOWLING AVENUE #1 NASHVILLE, TN 37205 | ExplanationTxt |
Schedule H IRS990ScheduleH
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Assistance Policy | Yes (true) | FinancialAssistancePolicyInd |
| Written Policy | Yes (true) | WrittenPolicyInd |
| FPG Reference Free Care | Yes (true) | FPGReferenceFreeCareInd |
Free Care Oth Percentage FreeCareOthPercentageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | Yes (X) | OtherInd |
| Free Care Other | 400. | FreeCareOtherPct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| FPG Reference Discounted Care | Yes (true) | FPGReferenceDiscountedCareInd |
| Percent400 | Yes (X) | Percent400Ind |
| Free Care Medically Indigent | Yes (true) | FreeCareMedicallyIndigentInd |
| Financial Assistance Budget | Yes (true) | FinancialAssistanceBudgetInd |
| Expenses Exceed Budget | Yes (true) | ExpensesExceedBudgetInd |
| Unable To Provide Care | false | UnableToProvideCareInd |
| Annual Community Bnft Report | Yes (true) | AnnualCommunityBnftReportInd |
| Report Publically Available | Yes (true) | ReportPublicallyAvailableInd |
Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $4,406,326 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $709,619 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $3,696,707 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01340 | TotalExpensePct |
Unreimbursed Medicaid UnreimbursedMedicaidGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $23,410,106 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $18,792,060 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $4,618,046 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01670 | TotalExpensePct |
Unreimbursed Costs UnreimbursedCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $872,960 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $504,868 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $368,091 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00130 | TotalExpensePct |
Total Financial Assistance Typ TotalFinancialAssistanceTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $28,689,392 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $20,006,547 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $8,682,844 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.03140 | TotalExpensePct |
Community Health Services CommunityHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $103,800 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $103,800 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00040 | TotalExpensePct |
Health Professions Education HealthProfessionsEducationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $8,041,416 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $1,685,620 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $6,355,796 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02300 | TotalExpensePct |
Subsidized Health Services SubsidizedHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 2 | ActivitiesOrProgramsCnt |
| Persons Served | 64 | PersonsServedCnt |
| Total Community Benefit Expns | $1,756,896 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $1,054,510 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $702,386 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00250 | TotalExpensePct |
Research ResearchGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $42,261,815 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $37,173,117 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $5,088,698 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01840 | TotalExpensePct |
Cash And In Kind Contributions CashAndInKindContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $47,885 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $47,885 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00020 | TotalExpensePct |
Total Other Benefits TotalOtherBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 2 | ActivitiesOrProgramsCnt |
| Persons Served | 64 | PersonsServedCnt |
| Total Community Benefit Expns | $52,211,812 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $39,913,247 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $12,298,565 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.04450 | TotalExpensePct |
Total Community Benefits TotalCommunityBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 2 | ActivitiesOrProgramsCnt |
| Persons Served | 64 | PersonsServedCnt |
| Total Community Benefit Expns | $80,901,204 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $59,919,794 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $20,981,409 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.07590 | TotalExpensePct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bad Debt Expense Reported | Yes (true) | BadDebtExpenseReportedInd |
| Bad Debt Expense | $4,494,660 | BadDebtExpenseAmt |
| Bad Debt Expense Attributable | $163,682 | BadDebtExpenseAttributableAmt |
| Reimbursed By Medicare | $56,514,465 | ReimbursedByMedicareAmt |
| Cost Of Care Reimbursed By Medcr | $60,498,946 | CostOfCareReimbursedByMedcrAmt |
| Medicare Surplus Or Shortfall | -$3,984,481 | MedicareSurplusOrShortfallAmt |
Costing Methodology Used CostingMethodologyUsedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cost Accounting System | Yes (X) | CostAccountingSystemInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Debt Collection Policy | Yes (true) | WrittenDebtCollectionPolicyInd |
| Financial Assistance Prvsn | Yes (true) | FinancialAssistancePrvsnInd |
| Hospital Facilities | 1 | HospitalFacilitiesCnt |
Hospital Facilities HospitalFacilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS EYE & EAR INFIRMARY | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02114 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Website Address | http://www.masseyeandear.org/ | WebsiteAddressTxt |
| State License | 2167 | StateLicenseNum |
| Licensed Hospital | Yes (X) | LicensedHospitalInd |
| Teaching Hospital | Yes (X) | TeachingHospitalInd |
| Research Facility | Yes (X) | ResearchFacilityInd |
| Emergency Room24 Hrs | Yes (X) | EmergencyRoom24HrsInd |
Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp
Hospital Facility Name HospitalFacilityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS EYE & EAR INFIRMARY | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Licensed CY Or PY | false | FirstLicensedCYOrPYInd |
| Tax Exempt Hospital CY Or PY | false | TaxExemptHospitalCYOrPYInd |
| CHNA Conducted | Yes (true) | CHNAConductedInd |
| Community Definition | Yes (X) | CommunityDefinitionInd |
| Community Demographics | Yes (X) | CommunityDemographicsInd |
| Existing Resources | Yes (X) | ExistingResourcesInd |
| How Data Obtained | Yes (X) | HowDataObtainedInd |
| Community Health Needs | Yes (X) | CommunityHealthNeedsInd |
| Other Health Issues | Yes (X) | OtherHealthIssuesInd |
| Community Hlth Needs Id Process | Yes (X) | CommunityHlthNeedsIdProcessInd |
| Consulting Process | Yes (X) | ConsultingProcessInd |
| Prior CHNA Impact | Yes (X) | PriorCHNAImpactInd |
| CHNA Conducted | 15 | CHNAConductedYr |
| Take Into Account Others Input | Yes (true) | TakeIntoAccountOthersInputInd |
| CHNA Conducted With Other Fclts | false | CHNAConductedWithOtherFcltsInd |
| CHNA Conducted With Non Fclts | false | CHNAConductedWithNonFcltsInd |
| CHNA Report Widely Available | Yes (true) | CHNAReportWidelyAvailableInd |
| Rpt Available On Own Website | Yes (X) | RptAvailableOnOwnWebsiteInd |
| Own Website URL | SEE SECTION C | OwnWebsiteURLTxt |
| Paper Copy Public Inspection | Yes (X) | PaperCopyPublicInspectionInd |
| Implementation Strategy Adopt | Yes (true) | ImplementationStrategyAdoptInd |
| Implementation Strategy Adpt | 15 | ImplementationStrategyAdptYr |
| Strategy Posted Website | Yes (true) | StrategyPostedWebsiteInd |
| Strategy Website URL | SEE SECTION C | StrategyWebsiteURLTxt |
| Strategy Attached | false | StrategyAttachedInd |
| Organization Incur Excise Tax | false | OrganizationIncurExciseTaxInd |
| Elig Criteria Explained | Yes (true) | EligCriteriaExplainedInd |
| FPG Family Incm Lmt Free Dscnt | Yes (X) | FPGFamilyIncmLmtFreeDscntInd |
| FPG Family Incm Lmt Free Care | 400. | FPGFamilyIncmLmtFreeCarePct |
| FPG Family Incm Lmt Dscnt Care | 400. | FPGFamilyIncmLmtDscntCarePct |
| Asset Level Criteria | Yes (X) | AssetLevelCriteriaInd |
| Medical Indigency Criteria | Yes (X) | MedicalIndigencyCriteriaInd |
| Insurance Status Criteria | Yes (X) | InsuranceStatusCriteriaInd |
| Underinsurance Stat Criteria | Yes (X) | UnderinsuranceStatCriteriaInd |
| Explained Basis | Yes (true) | ExplainedBasisInd |
| App Financial Asst Expln | Yes (true) | AppFinancialAsstExplnInd |
| Described Info | Yes (X) | DescribedInfoInd |
| Described Suprt Doc | Yes (X) | DescribedSuprtDocInd |
| Provided Hospital Contact | Yes (X) | ProvidedHospitalContactInd |
| Includes Publicity Measures | Yes (true) | IncludesPublicityMeasuresInd |
| FAP Available On Website | Yes (X) | FAPAvailableOnWebsiteInd |
| FAP Available On Website URL | SEE SECTION C | FAPAvailableOnWebsiteURLTxt |
| FAP App Available On Website | Yes (X) | FAPAppAvailableOnWebsiteInd |
| FAP App Available On Website URL | SEE SECTION C | FAPAppAvailableOnWebsiteURLTxt |
| FAP Summary On Website | Yes (X) | FAPSummaryOnWebsiteInd |
| FAP Summary On Website URL | SEE SECTION C | FAPSummaryOnWebsiteURLTxt |
| FAP Avlbl On Request No Charge | Yes (X) | FAPAvlblOnRequestNoChargeInd |
| FAP App Avlbl On Request No Chrg | Yes (X) | FAPAppAvlblOnRequestNoChrgInd |
| FAP Sum Avlbl On Request No Chrg | Yes (X) | FAPSumAvlblOnRequestNoChrgInd |
| Notified FAP Copy Bill Display | Yes (X) | NotifiedFAPCopyBillDisplayInd |
| FAP Translated | Yes (X) | FAPTranslatedInd |
| FAP Actions On Nonpayment | Yes (true) | FAPActionsOnNonpaymentInd |
| Permit No Actions | Yes (X) | PermitNoActionsInd |
| Collection Activities | false | CollectionActivitiesInd |
| None Made | Yes (X) | NoneMadeInd |
| Nondis Emergency Care Policy | Yes (true) | NondisEmergencyCarePolicyInd |
| Look Back Medicaid Medcr Prvt | Yes (X) | LookBackMedicaidMedcrPrvtInd |
| Amounts Generally Billed | false | AmountsGenerallyBilledInd |
| Gross Charges | false | GrossChargesInd |
Supplemental Information SupplementalInformationGrp (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, SECTION B, LINE 5 | TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MASS. EYE AND EAR CB WORKING GROUP TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES, AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS A MEMBER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES. |
| PART V, SECTION B, LINE 7A & LINE 10A | THE INFIRMARY'S COMMUNITY HEALTH NEEDS ASSESSMENT CAN BE VIEWED AT HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH |
| PART V, SECTION B, LINE 11 | THE MASSACHUSETTS EYE AND EAR COMMUNITY BENEFITS TEAM CONDUCTS AN ASSESSMENT AND PLANNING PROCESS THAT IDENTIFIES UNMET NEEDS IN TARGET POPULATIONS AND SERVICE AREAS, SPECIFICALLY ON POPULATIONS THAT FACE GREATER OBSTACLES TO CARE AND/OR ARE DISPROPORTIONALLY AFFECTED BY CONDITIONS THAT AFFECT THEIR DAILY FUNCTIONING AND QUALITY OF LIFE. THESE KEY AREAS ARE: CHILDREN, ELDERLY, LOW-INCOME PATIENTS, AND PATIENTS OF COLOR. OUR PLAN IS DESIGNED TO IMPROVE THE VISION, HEARING, AND OTHER CONDITIONS OF THE HEAD AND NECK AMONG VULNERABLE POPULATIONS IN OUR AREA. HEALTH SCREENINGS MASS. EYE AND EAR PROVIDES VISION SCREENINGS AND HEARING EXAMS AND FOLLOW UP CARE FOR INDIVIDUALS WITH LIMITED ACCESS TO SERVICES. SCREENINGS INCLUDED CAMP HARBOR VIEW, NEIGHBORHOOD HOUSE CHARTER SCHOOL, VISION COALITION/YEAR UP, AND ROXBURY TENANTS OF HARVARD. COMMUNITY EDUCATION AND SUPPORT GROUPS MASS. EYE AND EAR CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS DEALING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES, INCLUDING SINUSITIS, HEARING LOSS, VISION LOSS, AND FACIAL PARALYSIS. THEY ALSO ATTEND SEVERAL COMMUNITY HEALTH FAIRS. EVENTS INCLUDE "KNOW YOUR NOSE," LOW VISION SUPPORT GROUP, BOSTON CURED CANCER CLUB SUPPORT GROUP, FACIAL PARALYSIS SUPPORT GROUP, HEAR @ BOSTON, GRAVES DISEASE SUPPORT GROUP, AND VISION REHABILITATION. HEALTH FAIRS INCLUDED MISSION HILL, EMERSON HEALTH AND WELLNESS, AND STONEHAM TOWN DAY. ACCESS TO SERVICES/RESOURCES/WORK EXPERIENCE MASS. EYE AND EAR PROVIDES SERVICES AND RESOURCES TO INDIVIDUALS WHO MIGHT NOT BE ABLE TO ACCESS THEM AND PROVIDES TARGETED POPULATIONS WITH OPPORTUNITIES TO GAIN WORK EXPERIENCE. THIS INCLUDES PROJECT SEARCH, A PROGRAM THAT PROVIDES INTERNSHIPS FOR INDIVIDUALS WITH VISUAL IMPAIRMENT. OTHER SUPPORT INCLUDES TRANSPORTATION AND PARKING FOR NEEDY PATIENTS, VOLUNTEER ESCORTS, FREE EYEGLASSES, FREE MEDICATIONS, SOCIAL WORK CONSULTATIONS, FINANCIAL COUNSELING, HEARING AID CENTER SUPPORT, AND CHARITABLE CARE. MASS. EYE AND EAR PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. FINANCIAL SUPPORT MASS. EYE AND EAR PROVIDES FINANCIAL SUPPORT TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH OURS AND SUPPORT OUR COMMUNITY BENEFITS GOALS AND ADDRESSES ISSUES AS OUTLINED EARLIER IN THIS DOCUMENT. ORGANIZATIONS INCLUDE PERKINS SCHOOL FOR THE BLIND, NEW ENGLAND WALK FOR HEARING, ABCD FIELD OF DREAMS, SCHWARTZ CENTER FOR COMPASSIONATE CARE, ROXBURY TENANTS OF HARVARD, AND THE UNITED WAY. THESE STRATEGIES WERE EFFECTIVE IN ACHIEVING OUR COMMUNITY BENEFITS OBJECTIVES. MISSION HILL - OPPORTUNITY IDENTIFIED ONE AREA THAT WAS IDENTIFIED IN OUR LAST ASSESSMENT AS A NEW FOCUS AREA IS THE MISSION HILL NEIGHBORHOOD. MASS. EYE AND EAR OPENED A MULTI-SPECIALTY AMBULATORY CARE CENTER AT 800 HUNTINGTON AVENUE IN 2012. MASS. EYE AND EAR HAS DETERMINED A NEED TO BROADEN ITS COMMUNITY BENEFITS PROGRAM TO PROVIDE TARGETED PROGRAMMING IN THIS SMALL, DIVERSE COMMUNITY OF LOWER-INCOME RESIDENTS. MASS. EYE AND EAR PARTNERED WITH A HIGH SCHOOL (FENWAY HIGH SCHOOL) IN THE SPRING OF 2016 TO WELCOME THREE HIGH SCHOOL SENIORS FOR AN INTERNSHIP, IS ENGAGING LEADERS IN THE COMMUNITY TO CREATE NEIGHBORHOOD SPECIFIC PROGRAMMING, AND HOSTING EVENTS AT ITS FACILITY LOCATED AT 800 HUNTINGTON AVENUE. MASS. EYE AND EAR WILL FOCUS ON FURTHER INTEGRATION INTO THE NEIGHBORHOOD AND EXPLORE ADDITIONAL OPPORTUNITIES TO PROVIDE ADDITIONAL VISION AND HEARING SCREENINGS FOR SENIORS, FOLLOW-UP CARE AND EYE GLASSES, SPONSORSHIPS OF NEIGHBORHOOD EVENTS, PARTICIPATION IN HEALTH FAIRS, AND CONTRIBUTIONS TO COMMUNITY EVENTS. DURING THE REVIEW PROCESS, MASS. EYE AND EAR REVIEWED UNMET NEEDS, INCLUDING MISSION HILL, AND SET GOALS THAT ALIGN WITH THE GOAL OF THE ORGANIZATION'S COMMUNITY BENEFITS PLAN. AS A SPECIALTY HOSPITAL WITH 18 LOCATIONS (INCLUDING 243 CHARLES STREET AND 800 HUNTINGTON AVENUE), MASS. EYE AND EAR WORKS TO MEET NEEDS IN ITS SPECIALTY AREA, INCLUDING IMPROVING VISION AND HEARING, ENSURING TARGET POPULATIONS HAVE ACCESS TO EDUCATION AND SUPPORT. OTHER IDENTIFIED NEEDS OF THE COMMUNITY OUTSIDE OF OUR SPECIALTY AREAS ARE ADDRESSED BY OTHER INSTITUTIONS IN OUR COMMUNITY. |
| PART V, SECTION B, LINE 16A & 16B & 16C | THE INFIRMARY'S FINANCIAL ASSISTANCE POLICY CAN BE VIEWED AT HTTP://WWW.MASSEYEANDEAR.ORG/FOR-PATIENTS/PATIENT-GUIDE/FINANCIAL-ASSISTAN CE |
| PART V, SECTION B, LINE 22 | TO CALCULATE AMOUNTS GENERALLY BILLED (AGB), MASSACHUSETTS EYE AND EAR INFIRMARY (THE "HOSPITAL") USES THE "LOOK-BACK" METHOD. IN THIS METHOD, THE HOSPITAL DERIVES AN AGB PERCENTAGE BASED ON REIMBURSEMENT RATES FOR MASSHEALTH (PCC AND MMCO) ALONG WITH PRIVATE INSURERS AND MEDICARE FEE FOR SERVICE FOR A 12 MONTH PERIOD, DIVIDED BY THE GROSS CHARGES FOR THOSE CLAIMS. THE RESULTING PERCENTAGE IS MULTIPLIED BY GROSS CHARGES FOR ALL EMERGENCY AND MEDICALLY NECESSARY CARE TO DETERMINE THE AGB. THE AGB PERCENTAGE IS RECALCULATED ANNUALLY. |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 8 | FacilityNum |
Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp
Oth Hlth Care Fclts OthHlthCareFcltsGrp (8 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | FacilityFacilityTxt |
|---|---|---|---|---|
| MASSACHUSETTS EYE & EAR STONEHAM | ||||
| ONE MONTVALE AVENUE | STONEHAM | MA | 02180 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR E BRIDGEWATER | ||||
| ONE COMPASS WAY SUITE 100 | E BRIDGEWATER | MA | 02333 | LICENSED OUTPATIENT LOCATION |
| MEEI VESTIBULAR CENTER AT BRAINTREE | ||||
| 250 POND STREET 1ST FLOOR | BRAINTREE | MA | 02184 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR QUINCY | ||||
| 500 CONGRESS STREET | QUINCY | MA | 02169 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR AT JOSLIN | ||||
| 1 JOSLIN PLACE | BOSTON | MA | 02215 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR CONCORD | ||||
| 54 BAKER AVE EXTENSION 3RD FL STE | CONCORD | MA | 01742 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR LONGWOOD | ||||
| 800 HUNTINGTON AVENUE | BOSTON | MA | 02115 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR PLAINVILLE | ||||
| 30 MAN MAR DRIVE STE 2 | PLAINVILLE | MA | 02762 | LICENSED OUTPATIENT LOCATION |
Supplemental Information Detail SupplementalInformationDetail (24 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE H, PART I, LINE 3C | IN ADDITION TO FPG, THE ORGANIZATION CONSIDERS ASSETS, UNPAID MEDICAL EXPENSES, AND EXTRAORDINARY FINANCIAL CIRCUMSTANCES (UNEMPLOYMENT AND OTHER FINANCIAL STRESSES) WHEN REVIEWING AN INDIVIDUALS APPLICATION FOR FINANCIAL ASSISTANCE. |
| SCHEDULE H, PART II | THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND ITS AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, AND FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 21 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS. |
| SCHEDULE H, PART III, LINES 2 - 4 | BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT. SEE FINANCIAL STATEMENT, PAGES 25 27. |
| SCHEDULE H, PART III, LINE 8 | THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER. |
| SCHEDULE H, PART III, LINE 9B | PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBLE FOR FINANCIAL ASSISTANCE. |
| SCHEDULE H, PART VI, LINE 2 | MASS. EYE AND EAR ENGAGED THE SERVICES OF CONSULTANTS TO JOIN THE CB WORKING GROUP AND GUIDE THE ASSESSMENT PROCESSES, WHICH TOOK PLACE DURING THE FALL 2015/WINTER 2016. THE NEXT ASSESSMENT PROCESS WILL BEGIN IN THE FALL OF 2018. KENEFICK AND BAXTER HAD WORKED WITH MASS. EYE AND EAR ON ITS LAST TWO ASSESSMENTS AS WELL. THE NEEDS ASSESSMENT WAS A THREE-STEP PROCESS DESIGNED TO: (1) IDENTIFY THE MASS. EYE AND EAR TARGET AREAS AND POPULATIONS FOR ITS COMMUNITY BENEFIT PLAN (2) ASSESS UNMET NEEDS IN THE SERVICE AREA AND AMONG TARGET POPULATIONS (3) ASSESS NEEDS IN MISSION HILL FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILABLE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING, AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MASS. EYE AND EAR HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN. |
| SCHEDULE H, PART VI, LINE 3 | MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF OUR PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A DEDICATED PAGE WHICH HIGHLIGHTS THE BASIC FEDERAL, AND MASSACHUSETTS EYE AND EAR, PROGRAMS. IT ALSO PROVIDES CONTACT INFORMATION FOR MEEI'S FINANCIAL COORDINATORS. THE FINANCIAL COORDINATION PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED. INFORMATION RELATING TO THE AVAILABILTY OF FINANCIAL ASSISTANCE IS ALSO GENERATED ON EACH OF OUR PATIENT STATEMENTS AND HAS BEEN TRANSLATED FOR THOSE INDIVIDUALS WHO MAY HAVE LIMITED ENGLISH PROFICIENCY. |
| SCHEDULE H, PART VI, LINE 4 | STEP 1. IDENTIFY MASS. EYE AND EAR'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MASS. EYE AND EAR COMMUNITY BENEFIT PLAN BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2014 THROUGH MARCH 31, 2015) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 91,915 PATIENTS WHO UTILIZED SERVICES AT MASS. EYE AND EAR'S MAIN CAMPUS AND ITS LONGWOOD FACILITY. BELOW, OBSERVATIONS ABOUT PATIENTS SEX, RACE/ETHNICITY, AGE, SES, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. BELOW, THE FINDINGS ABOUT PATIENTS' SEX, RACE/ETHNICITY, GEOGRAPHIC LOCATION, AND SES ARE PROVIDED AND ARE FOLLOWED BY PROFILES OF MASS. EYE AND EAR'S PATIENTS OF COLOR, LOW-INCOME AND UN/UNDER-INSURED PATIENTS, AND ITS PEDIATRIC AND GERIATRIC PATIENTS. SEX: OVER HALF (54.7%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 81% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT MASS. EYE AND EAR. FIGURE BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (64.4%) ARE WHITE. RACE/ETHNICITY OF MASS. EYE AND EAR PATIENTS AMERICAN INDIAN/ALASKA NATIVE 191 0.2% ASIAN 4,126 4.2% BLACK/AFRICAN AMERICAN 6,062 6.6% HISPANIC 3,961 4.3% PACIFIC ISLANDER 38 .3% WHITE 59,166 64.4% OTHER 685 0.7% UNKNOWN 17,686 19.2% TOTAL 91,915 100.0% GEOGRAPHY: JUST UNDER 20% OF MASS. EYE AND EAR'S PATIENTS RESIDE IN BOSTON. ANOTHER 39.7% LIVE IN THE SUBURBAN COMMUNITIES AROUND BOSTON AND WITHIN THE 128 BELT, AND 25.4% LIVE WEST OF 128, BUT STILL EAST OF INTERSTATE 495. THE REMAINING 15.5% OF PATIENT LIVE ELSEWHERE IN MA (E.G., WEST OF INTERSTATE 495 OR ON THE CAPE OR ISLANDS). GEOGRAPHIC LOCATION OF MASS. EYE AND EAR PATIENTS LIVING IN MASSACHUSETTS BOSTON 17,794 19.4% WITHIN 128 (EXCEPT BOSTON) 36,517 39.7% EAST OF 495/WEST OF 128 23,336 25.4% ELSEWHERE IN MA 14,268 15.5% BOSTON IS HOME TO THE LARGEST CONCENTRATION OF MASS. EYE AND EAR PATIENTS (19.4%) FOLLOWED BY 15 OTHER COMMUNITIES. WITH THE EXCEPTION OF ANDOVER, 14 OF THESE 15 COMMUNITIES ARE WITHIN THE 128 BELT. TOGETHER WITH BOSTON, THESE COMMUNITIES ARE HOME TO 47.2% OF MASS. EYE AND EAR'S PATIENTS. COMMUNITIES OUTSIDE OF BOSTON THAT ARE HOME TO LARGEST CONCENTRATIONS OF PATIENTS CAMBRIDGE 3,476 3.8% REVERE 2,187 2.40% NEWTON 2,080 2.3% QUINCY 1,983 2.20% SOMERVILLE 1,976 2.10% BROOKLINE 1,840 2.0% CHELSEA 1,769 1.9% MEDFORD 1,700 1.8% MALDEN 1,672 1.8% LYNN 1,434 1.6% EVERETT 1,326 1.4% ANDOVER 1,117 1.2% ARLINGTON 1,101 1.2% WALTHAM 979 1.10% WINTHROP 890 1.00% TOTAL 25,530 27.8% |
| NOTE THAT WITHIN THE DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN | BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTONS 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 13 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 13 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MASS. EYE AND EAR PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MASS. EYE AND EAR PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. NEIGHBORHOOD OF MASS. EYE AND EAR'S PATIENTS WHO RESIDE IN BOSTON BOSTON 5,590 31.4% SOUTH BOSTON 893 5.0% DORCHESTER 2,692 15.1% WEST ROXBURY 776 4.4% EAST BOSTON 1,353 7.6% HYDE PARK 719 4.0% CHARLESTOWN 1,195 6.7% ROSLINDALE 713 4.0% JAMAICA PLAIN 1,171 6.6% MATTAPAN 560 3.1% BRIGHTON 917 5.2% ALLSTON 321 1.8% ROXBURY 894 5.0% SOCIO-ECONOMIC STATUS: DETERMINING THE SOCIO-ECONOMIC STATUS (SES) OF PATIENTS IS CHALLENGING. HOWEVER, MEANS-TESTED PUBLIC HEALTH INSURANCE PLANS (E.G., MASSHEALTH, NETWORK HEALTH, BMC HEALTH NET, HEALTH SAFETY NET) MAY BE USED AS A PROXY FOR LOWER SES. ADDITIONALLY, THOSE WHOSE PAYER WAS LISTED AS A SOURCE OF CHARITABLE CARE OR WHO ARE LISTED AS SELF-PAY ARE CONSIDERED UNINSURED OR UNDERINSURED. THESE PROXIES LIKELY LEAD TO AN UNDER-ESTIMATION OF THE PERCENTAGE OF LOW-INCOME PATIENTS. FOR EXAMPLE, MOST PATIENTS WHO ARE 65 AND OVER HAVE SOME FORM OF MEDICARE AS THEIR PAYMENT METHOD, WHICH PROVIDES NO INDICATION OF SES. DESPITE SUCH LIMITATIONS, THE DATA INDICATE THAT AT LEAST 15.1% OF MASS. EYE AND EAR'S PATIENTS ARE LOW-INCOME AND 2.2% ARE UNINSURED OR UNDER-INSURED. PROFILES OF MASS. EYE AND EAR'S LOW-INCOME PATIENTS AND PATIENTS OF COLOR: PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED BASED ON PAYMENT METHOD DATA, AT LEAST 15,846 (17.2%) OF MASS. EYE AND EAR PATIENTS ARE OF LOWER SES OR ARE UNINSURED OR UNDER-INSURED. MORE THAN HALF (55.1%) OF THESE PATIENTS ARE WOMEN. THE MEAN AGE OF THESE PATIENTS IS 40.82 WITH A RANGE OF 2 TO 102. PEOPLE OF COLOR MAKE UP 30.2% OF THE PATIENTS WHO HAVE LOWER SES AND WHO ARE UN- OR UNDER-INSURED COMPARED TO 16.4% OF THE TOTAL MASS. EYE AND EAR PATIENT POPULATION. RACIAL CATEGORY OF PATIENT WITH LOW SES OR WHO ARE UN/UNDER-INSURED (TOTAL PATIENT POPULATION -- LOW SES & UN/UNDER-INSURED) RACE/ETHNICITY: #; % -- #; % WHITE 59,166; 64.4% -- 7,184; 45.3% PEOPLE OF COLOR 15,063; 16.4% -- 4,789; 30.2% UNKNOWN 17,686; 19.2% -- 3,873; 24.4% TOTAL: 91,915; 100.0% -- 15,846; 100.0% JUST OVER 70% OF PATIENTS WITH LOWER SES OR WHO ARE UN- OR UNDER-INSURED LIVE WITHIN THE 128 BELT, WITH 23.9% OF THOSE RESIDING IN BOSTON. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S LOW-INCOME OR UN/UNDER-INSURED PATIENTS BOSTON: 3,794; 23.9% WITHIN 128 (EXCLUDING BOSTON): 7,330; 46.3% EAST OF 495/WEST OF 128: 2,688; 17.0% ELSEWHERE IN MA: 2,034; 12.8% TOTAL: 15,846; 100.0% |
| OUTSIDE OF BOSTON, 14 COMMUNITIES ARE HOME TO THE HIGHEST | CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UNINSURED OR UNDER-INSURED. WITH THE EXCEPTION OF BROCKTON AND LAWRENCE, ALL OF THESE COMMUNITIES ARE WITHIN THE 128 BELT. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED. CHELSEA: 895; 5.6% REVERE 735; 4.6% CAMBRIDGE: 559; 3.5% LYNN: 542; 3.4% EVERETT: 531; 3.4% MALDEN: 470; 3.0% SOMERVILLE: 439; 2.8% QUINCY; 351; 2.2% MEDFORD: 307; 1.9% NEWTON: 198; 1.2% BROCKTON: 192; 1.2% LAWRENCE: 181; 1.1% WALTHAM: 180; 1.1% SAUGUS: 153; 1.0% TOTAL: 5,733; 36.0% PATIENTS OF COLOR: JUST OVER ONE-THIRD (35.6%) OF MASS EYE AND EAR PATIENTS IDENTIFIED AS BEING HISPANIC OR OF A RACE OTHER THAN WHITE. MOST OF THESE PATIENTS OF COLOR SELF-IDENTIFIED AN ETHNIC IDENTITY AS WELL: ASIAN (E.G., CAMBODIAN, CHINESE, JAPANESE, KOREAN, LAOTIAN, VIETNAMESE, ASIAN INDIAN); BLACK/AFRICAN AMERICAN (E.G., AFRICAN, CAPE VERDEAN, CARIBBEAN ISLANDER, HAITIAN); AND HISPANIC (E.G., BRAZILIAN, CUBAN, DOMINICAN, GUATEMALAN, HONDURAN, MEXICAN, PORTUGUESE, PUERTO RICAN, SALVADORAN). MANY WHO IDENTIFIED THEIR RACE AS "OTHER" OFFERED MIDDLE EASTERN OR NORTH AFRICAN AS THEIR ETHNICITY. IN ALL, 15,063 (16.4%) OF MASS. EYE AND EAR'S PATIENTS ARE HISPANIC OR A RACE OTHER THAN WHITE. OF THESE PATIENTS, 57.5% ARE FEMALE. THE AVERAGE AGE OF THESE PATIENTS IS 48.27 WITH A RANGE OF 2 TO 104. 76.7% OF THESE PATIENTS OF COLOR LIVE IN BOSTON (34.5%) AND SUBURBAN COMMUNITIES WITHIN THE ROUTE 128 BELT (42.2%). THE LARGEST CONCENTRATIONS OF PATIENTS OF COLOR OUTSIDE OF BOSTON ARE IN EIGHT COMMUNITIES WITHIN THE 128 BELT. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S PATIENTS OF COLOR BOSTON: 5,194; 34.5% WITHIN 128 (EXCLUDING BOSTON): 6,352; 42.2% EAST OF 495/WEST OF 128: 2,210; 14.7% ELSEWHERE IN MA: 1,307; 8.6% TOTAL: 15,063; 100.0% A COMPARISON OF THE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN- OR UNDER-INSURED WITH THOSE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENT OF COLOR SHOW OVERLAP. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF PATIENTS OF COLOR CAMBRIDGE*: 843; 5.6% CHELSEA*: 677; 4.5% MALDEN*: 532; 3.5% LYNN*: 449; 3.0% REVERE*: 421; 2.8% EVERETT*: 401; 2.7% SOMERVILLE*: 386; 2.6% QUINCY*: 374; 2.5% BROCKTON*: 341; 2.3% MEDFORD*: 286; 1.9% BROOKLINE: 271; 1.8% RANDOLPH: 272; 1.8% NEWTON*: 243; 1.6% WALTHAM*: 166; 1.1% LAWRENCE*: 159; 1.1% LEXINGTON: 157; 1.0% *COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED |
| BASED ON PAYMENT METHOD, 29.8% OF MASS. EYE AND EAR'S PATIENTS | OF COLOR HAVE LOW SES AND 2% ARE UNINSURED OR UNDER-INSURED. MOST (81%) OF THESE PATIENTS LIVE WITHIN THE 128 BELT WITH 32.7% OF THEM RESIDING IN BOSTON. FIGURE BELOW SHOWS THE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR WITH LOW SES OR WHO ARE UNINSURED OR UNDER-INSURED. ALL BUT LOWELL APPEAR ON BOTH THE LIST OF COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR AND PATIENTS WITH LOW SES AND WHO ARE UN- OR UNDER-INSURED. COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR WITH LOW SES OR WHO ARE UN/UNDER-INSURED BROCKTON*+: 97; 2.0% BROOKLINE*: 54; 1.0% CAMBRIDGE*+: 218; 4.6% EVERETT*+: 207; 4.3% LOWELL 50; 1.0% LYNN*+: 229; 4.8% MALDEN*+: 200; 4.2% MEDFORD*+: 87; 1.6% QUINCY*+: 109; 2.3% REVERE*+: 209; 4.4% SOMERVILLE*+: 147; 3.1% WALTHAM*+: 52; 1.1% *COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED +COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR THE OVERLAP IN COMMUNITIES SUGGESTS THAT CONCENTRATING IN THE COMMUNITIES IN WHICH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN- OR UNDER-INSURED WILL ALSO ENSURE THAT COMMUNITY BENEFIT ACTIVITIES REACH THOSE COMMUNITIES IN WHICH THE HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S PATIENTS OF COLOR LIVE, INCLUDING THOSE WHO HAVE LOW SES OR WHO ARE UN- OR UNDERINSURED. GIVEN THE LOCATION OF MOST OF THE THESE COMMUNITIES, IT MAKES SENSE TO CONCENTRATE MASS. EYE AND EAR'S COMMUNITY BENEFIT ACTIVITIES WITHIN THE 128 BELT TO HELP TO ENSURE THAT ITS PATIENTS OF COLOR AND THOSE WITH LOW SES AND LITTLE OR NO INSURANCE WILL BENEFIT. PROFILE OF MASS. EYE AND EAR'S GERIATRIC AND PEDIATRIC POPULATIONS: MASS. EYE AND EAR HAS CLINICAL EXPERTISE IN SERVING PEDIATRIC AND GERIATRIC PATIENTS. THESE POTENTIALLY VULNERABLE GROUPS WERE SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MASS. EYE AND EAR'S COMMUNITY BENEFITS PLAN DUE TO THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. SENIORS (AGE 65+): PATIENTS AGED 65 AND OVER MAKE UP 31.6% OF THOSE SEEN AT MASS. EYE AND EAR DURING THE SELECTED TIMEFRAME, A TOTAL OF 29,060 INDIVIDUALS. AMONG SENIOR PATIENTS, 56.2% ARE FEMALE. THE AVERAGE AGE OF THE SENIOR GROUP IS 74.67 WITH A RANGE OF 65 TO 104. FOR MASS. EYE AND EAR'S SENIORS IN GENERAL, NEARLY 60% LIVE WITHIN THE 128 BELT WITH 18.6% OF THOSE RESIDING IN BOSTON. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S GERIATRIC PATIENTS BOSTON: 5,404; 18.6% WITHIN 128 (EXCLUDING BOSTON): 11,812; 40.6% EAST OF 495/WEST OF 128: 7,258; 25.0% ELSEWHERE IN MA: 4,586; 15.8% TOTAL: 29,060; 100.0% BECAUSE MOST SENIORS HAVE SOME FORM OF MEDICARE FOR HEALTH CARE COVERAGE, THE PAYER DATA ARE NOT PARTICULARLY USEFUL IN HELPING US TO UNDERSTAND WHICH OF THE SENIOR PATIENTS ARE LOW-INCOME. AMONG THE 29,060 SENIOR PATIENTS, 1,095 (3.8%) HAD SOME FORM OF MEDICAID (E.G., MASSHEALTH, EMERGENCY MEDICAID, NETWORK HEALTH) AS THEIR PAYER AND 508 (1.7%) WERE LISTED AS SELF-PAY, WHICH LIKELY INDICATES THAT THEY HAD NO COVERAGE FOR THE SERVICES THEY RECEIVED AT MASS. EYE AND EAR. AMONG THE SENIORS WHO MAY BE LOW INCOME OR WHO ARE UN- OR UNDER-INSURED, 72.5% LIVE WITHIN THE 128 BELT WITH 21.9% OF THOSE SENIORS LIVING IN BOSTON. FIGURE BELOW SHOWS THE 15 COMMUNITIES WITH THE LARGEST CONCENTRATION OF MASS EYE AND EAR'S SENIOR PATIENTS, AS WELL AS THOSE WHERE THE LARGEST CONCENTRATION OF LOW-INCOME OR UN- OR UNDER-INSURED SENIORS RESIDE. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S SENIORS AND SENIORS WITH LOW SES OR WHO ARE UN/UNDER-INSURED (SENIORS -- LOW INCOME SENIORS) CAMBRIDGE: 1,112; 3.8% -- 80; 5.0% NEWTON: 772; 2.7% -- 45; 2.8% REVERE: 679; 2.3% -- 61; 3.8% BROOKLINE: 672; 2.3% -- 51; 3.2% QUINCY: 665; 2.3% -- 33; 2.1% SOMERVILLE 553; 1.9% -- 45; 2.8% MALDEN 486; 1.7% -- 45; 2.8% CHELSEA: 391; 1.3% -- 54; 3.4% ARLINGTON: 376; 1.3% -- 26; 1.6% ANDOVER*: 370; 1.3% LYNN: 369 1.3% -- 49; 3.1% WINTHROP: 352; 1.2% EVERETT: 333; 1.1% -- 31; 1.9% LEXINGTON: 317; 1.1% WALTHAM: 283; 1.0% -- 20; 1.2% MEDFORD: 39; 2.4% FRAMINGHAM*:24; 1.5% WATERTOWN: 20; 1.2% |
| BECAUSE PAYOR DATA PROVIDE LITTLE INSIGHT INTO THE SES OF THE | LARGER GERIATRIC PATIENT POPULATION, U.S. CENSUS DATA WERE ALSO EXAMINED TO UNDERSTAND THE DEMOGRAPHIC PROFILES (I.E., PROPORTION OF SENIORS AND THOSE LIVING BELOW THE POVERTY LEVEL) WHO LIVE IN EACH OF THE 18 COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S GERIATRIC PATIENTS. SEVEN OF THE COMMUNITIES HAVE A LARGER PROPORTION OF SENIOR RESIDENTS THAN THE STATE IN GENERAL AND EIGHT HAVE A LARGER PROPORTION OF RESIDENTS LIVING BELOW THE POVERTY LEVEL THAN THE STATE IN GENERAL. ALTHOUGH REVERE IS THE ONLY OF THE COMMUNITIES WITH A HIGHER PROPORTION OF BOTH GROUPS THAN MASSACHUSETTS IN GENERAL, MANY OF THE 15 COMMUNITIES WITH THE HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S GERIATRIC PATIENTS ALSO HAVE HIGH RATES OF POVERTY. EXCEPT FOR ANDOVER, ALL OF THESE COMMUNITIES ARE WITHIN THE 128 BELT, WHICH SUGGESTS THAT CONCENTRATING COMMUNITY BENEFIT PROGRAMMING ON COMMUNITIES WITHIN THE 128 BELT WILL HAVE THE GREATEST LIKELIHOOD OF REACHING MASS. EYE AND EAR'S GERIATRIC PATIENTS, INCLUDING MANY WHO LIVE IN COMMUNITIES THAT ARE DISPROPORTIONATELY AFFECTED BY POVERTY. U.S. CENSUS DATA ON RESIDENTS 65+ AND POVERTY IN COMMUNITIES IN WHICH THE LARGEST CONCENTRATION OF MASS. EYE AND EAR SENIOR PATIENTS RESIDE (2014 US CENSUS POPULATION ESTIMATE; RESIDENTS 65+; RESIDENTS LIVING BELOW POVERTY LEVEL) MASSACHUSETTS: 6,745,408; 13.8%; 11.4% CAMBRIDGE: 109,694; 9.5%; 14.7% NEWTON: 88,287; 15.2%; 5.7% REVERE: 54,157; 14.5%; 15.4% BROOKLINE*: 58,732; 12.8%; 11.5% QUINCY: 93,397; 15.1%; 10.5% SOMERVILLE: 78,901; 9.1%; 14.8% MALDEN: 60,859; 11.8%; 16.0% CHELSEA: 38,861; 8.7%; 23.7% ARLINGTON*: 42,844; 15.8%; 3.9% ANDOVER*: 8,762; 18.5%; 7.4% LYNN: 92,137; 11.4%; 21.0% WINTHROP: 18,352; 16.5%; 9.2% EVERETT: 44,231; 11.5%; 13.2% LEXINGTON*: 31,394; 18.6%; 3.9% WALTHAM: 63,014; 12.3%; 10.1% *2014 ESTIMATE NOT AVAILABLE. DATA ARE FROM 2010 U.S. CENSUS CHILDREN (UNDER 18 YEARS OLD): IN THE SELECTED TIMEFRAME, MASS. EYE AND EAR PROVIDED SERVICES TO 8,725 PATIENTS UNDER THE AGE OF 18. THESE CHILDREN COMPRISE 9.5% OF THE TOTAL PATIENT POPULATION. THE PEDIATRIC POPULATION IS MADE UP OF MORE MALES (56.3%) THAN FEMALES AND WHITE (56%) PATIENTS THAN THOSE IN OTHER RACIAL/ETHNIC GROUPS. THE PAYER SOURCE FOR THESE PATIENTS INDICATES THAT 30.2% ARE OF LOWER SES AND 1% IS UN- OR UNDER-INSURED. OVER HALF (53.5%) LIVE WITHIN THE 128 BELT WITH 12.1% RESIDING IN BOSTON. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S PEDIATRIC PATIENTS (N=8,725) BOSTON: 1,057; 12.1% WITHIN 128 (EXCLUDING BOSTON): 3,610; 41.4% EAST OF 495/WEST OF 128: 2,679; 30.7% ELSEWHERE IN MA: 1,379; 15.8% OVER TWO-THIRDS (67.7%) OF PEDIATRIC PATIENTS WITH LOW SES OR WHO ARE UN- OR UNDER-INSURED LIVE IN COMMUNITIES WITHIN THE 128 BELT, INCLUDING BOSTON (15.1%). FIGURE 15 SHOWS THE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PEDIATRIC PATIENTS, AS WELL AS THOSE WITH THE HIGHEST CONCENTRATION OF PEDIATRIC PATIENTS WHO HAVE LOW SES OR WHO ARE UN- OR UNDER-INSURED. TWELVE COMMUNITIES OUTSIDE OF BOSTON THAT ARE HOME TO THE HIGHEST CONCENTRATION OF PEDIATRIC PATIENTS ARE ALSO HOME TO THE HIGHEST CONCENTRATION OF CHILDREN WHO HAVE LOW SES OR WHO ARE UN- OR UNDER-INSURED. WITH THE EXCEPTION OF BROCKTON, LAWRENCE, AND HAVERHILL, ALL OF THE HIGHEST CONCENTRATION COMMUNITIES IN WHICH THESE LOW-INCOME CHILDREN LIVE ARE WITHIN THE 128 BELT. THESE DATA SUGGEST THAT CONCENTRATING COMMUNITY BENEFIT PROGRAMMING ON COMMUNITIES WITHIN THE 128 BELT WILL HAVE THE GREATEST LIKELIHOOD OF REACHING MASS. EYE AND EAR'S PEDIATRIC PATIENTS, INCLUDING MANY WHO ARE LOW-INCOME. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S PEDIATRIC PATIENTS AND THOSE WITH LOW SES OR WHO ARE UN/UNDER-INSURED |
| (CHILDREN ; LOW INCOME CHILDREN) | CHELSEA 322 3.7% ; 253 9.3% REVERE: 284 3.3% ; 197 7.2% CAMBRIDGE: 252 2.9% ; 87 3.2% EVERETT: 209 2.4% ; 149 5.5% NEWTON: 200 2.3% LYNN: 187 2.1% ; 132 4.9% SOMERVILLE: 170 1.9% ; 87 3.2% MALDEN: 164 1.9% ; 98 3.6% QUINCY: 160 1.8% ; 54 2.0% BROOKLINE: 129 1.5% ANDOVER: 120 1.4% WALTHAM: 112 1.3% ; 32 1.2% BROCKTON: 107 1.2% ; 56 2.1% MEDFORD: 103 1.2% ; 36 1.3% MILTON: 103 1.2% HAVERHILL: 97 1.1% ; 41 1.5% BRAINTREE: 92 1.1% LEXINGTON: 88 1.0% NATICK: 86 1.0% WELLESLEY: 85 1.0% LAWRENCE: 34 1.3% PEABODY: 27 1.0% SAUGUS: 29 1.1% WINTHROP: 26 1.0% SUFFOLK COUNTY AND MUCH OF MIDDLESEX COUNTY ARE LOCATED WITHIN THE 128 BELT, WHERE MOST OF MASS. EYE AND EAR'S PATIENTS RESIDE AND WHERE THE LARGEST CONCENTRATIONS OF VULNERABLE PATIENTS (E.G., CHILDREN, SENIORS, THOSE WITH LOW SES OR WHO ARE UN/UNDER-INSURED) LIVE. THE U.S. CENSUS DATA FOR MASSACHUSETTS' COUNTIES SHOW THAT: SUFFOLK COUNTY IS HOME TO THE LARGEST NUMBER AND HIGHEST PERCENTAGE OF THE STATE'S RESIDENTS LIVING BELOW THE FEDERAL POVERTY LEVEL. TOGETHER, SUFFOLK AND MIDDLESEX COUNTIES ARE HOME TO 28.9% OF THE COMMONWEALTH'S RESIDENTS WHO LIVE BELOW THE POVERTY LINE. MIDDLESEX COUNTY IS HOME TO THE LARGEST NUMBER OF SENIOR CITIZENS (AGE 65 AND OVER) AND THAT, TOGETHER, MIDDLESEX AND SUFFOLK COUNTIES ARE HOME TO 35% OF THE COMMONWEALTH'S SENIORS. MIDDLESEX COUNTY IS HOME TO THE LARGEST NUMBER AND HIGHEST PERCENTAGE OF THE STATE'S CHILDREN (UNDER AGE 18) AND, TOGETHER, MIDDLESEX AND SUFFOLK COUNTIES ARE HOME TO 37.9% OF THE COMMONWEALTH'S CHILDREN UNDER AGE 18. SENIORS, CHILDREN, AND THOSE LIVING BELOW THE POVERTY LINE IN MA COUNTIES. (POPULATION ; # LIVING BELOW POVERTY LINE ; % LIVING BELOW POVERTY LINE ; # OF SENIORS (65+) ; % SENIORS (65+) ; # OF CHILDREN (UNDER 18) ; % OF CHILDREN (UNDER 18)) MASSACHUSETTS: 674,540: 768,977 11.4%; 930,866 13.8%; 1,389,554 20.6% BARNSTABLE: 214,914: 19,987 9.3%; 59,746 27.8%; 34,171 15.9% BERKSHIRE: 128,715: 16,476 12.8%; 26,901 20.9%; 23,040 17.9% BRISTOL: 554,194: 68,720 12.4%; 87,008 15.7%; 116,935 21.1% DUKES: 17,356: 1,753 10.1%; 3,436 19.8%; 3,176 18.3% ESSEX: 769,091: 86,138 11.2%; 119,978 15.6%; 169,200 22.0% FRANKLIN: 70,862: 8,574 12.1%; 12,897 18.2%; 12,897 18.2% HAMPDEN: 468,161: 82,864 17.7%; 71,629 15.3%; 105,336 22.5% HAMPSHIRE: 160,939: 20,922 13.0%; 23,658 14.7%: 25,106 15.6% MIDDLESEX: 1,570,315: 127,196 8.1%; 219,844 14.0%; 323,485 20.6% NANTUCKET: 10,856: 1,129 10.4%; 1,455 13.4%; 2,269 20.9% NORFOLK: 692,254: 45,689 6.6%; 108,684 15.7%; 149,527 21.6% PLYMOUTH: 507,022: 38,534 7.6% ; 82,138 16.2%; 114,080 22.5% SUFFOLK: 767,254: 159,589 20.8%; 84,398 11.0%; 132,735 17.3% WORCESTER: 813,475: 91,109 11.2%; 114,700 14.1%; 178,965 22.0% BY CONCENTRATING ON THE 128 BELT WITH SOME EFFORTS THAT EXTEND STATEWIDE (ESPECIALLY IN THE AREA BETWEEN 128 AND INTERSTATE 495), MASS. EYE AND EAR WILL LIKELY REACH THE GREATEST CONCENTRATION OF ITS CURRENT PATIENTS, ITS MOST VULNERABLE PATIENTS (I.E., SENIORS, CHILDREN, THOSE WITH LOW SES), AS WELL AS NON-PATIENTS WHO ARE SENIORS, CHILDREN, AND THOSE LIVING IN POVERTY WHO MAY BENEFIT FROM MASS. EYE AND EAR'S COMMUNITY BENEFIT ACTIVITIES. ACCORDING TO THE DONAHUE INSTITUTE AT THE UNIVERSITY OF MASSACHUSETTS, THE SENIOR POPULATION (65+) IS PROJECTED TO STEADILY INCREASE OVER THE NEXT 15 YEARS WHEREAS THE POPULATION OF CHILDREN WILL REMAIN RELATIVELY STABLE PROJECTED PROPORTIONS OF SENIORS AND CHILDREN IN MA (2015-2030) |
| (SENIORS; CHILDREN) | 2015: 15.3%; 22.9% 2020: 16.9%; 22.4% 2025: 19.1%; 22.3% 2030: 21.1%; 22.5% THESE PROJECTIONS SUGGEST THAT THE NEED FOR MASS. EYE AND EAR'S COMMUNITY BENEFIT ACTIVITIES TARGETING SENIORS AND CHILDREN WILL PERSIST (AND EVEN GROW FOR SENIORS) OVER THE THREE YEARS OF THIS PLAN. CONCLUSIONS: BASED ON THE CENSUS DATA AND MASS EYE AND EAR'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MASS. EYE AND EAR CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITALS PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES WITHIN THE ROUTE 128 BELT. ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF CHILDREN, ELDERLY, AND LOW-INCOME PATIENTS AND PATIENTS OF COLOR RESIDE WITHIN THIS SERVICE AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MASS EYE AND EAR'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. DUE TO THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS AND PEOPLE OF COLOR VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MASS. EYE AND EAR SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN. |
| STEP 2. ASSESS UNMET NEEDS IN THE SERVICE AREA AND AMONG THE TARGET | POPULATIONS WITH DATA FROM PROVIDERS AND STAFF AT MASS. EYE AND EAR AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES, THE CB WORKING GROUP IDENTIFIED THE UNMET NEEDS THAT, AS AN INSTITUTION, MASS. EYE AND EAR IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE FALL AND WINTER, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE SIMILAR TO THOSE IDENTIFIED IN THE HOSPITAL'S LAST COMMUNITY BENEFITS PLAN. -TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. -FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK. -FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. -FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. -FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MASS. EYE AND EAR SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. -FOR FINANCIAL SUPPORT OF NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN INCOME DISPARITIES, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MASS. EYE AND EAR WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE CB WORKING GROUP AND THE HOSPITAL LEADERSHIP CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF THE HOSPITAL AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR THE FY16-18 COMMUNITY BENEFITS PLAN. |
| STEP 3. ASSESS NEEDS IN MISSION HILL | AS NOTED EARLIER, MASS. EYE AND EAR DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN THE MISSION HILL NEIGHBORHOOD IN 2012 WITH THE OPENING OF A MULTI-SPECIALTY AMBULATORY CARE CENTER AT 800 HUNTINGTON AVENUE ON MISSION HILL. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING TO A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. THE RANGE OF COUNTRIES OF ORIGIN DEMONSTRATES THE RICH ETHNIC DIVERSITY OF MISSION HILL RESIDENTS. ROUGHLY HALF OF MISSION HILL'S CHILDREN AND 60% OF ADULTS SPEAK A FOREIGN LANGUAGE AT HOME AND MANY EXPERIENCE LINGUISTIC ISOLATION BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. LANGUAGES REPRESENTED INCLUDE SPANISH (35.1%), INDO-EUROPEAN LANGUAGES (38%), ASIAN AND PACIFIC ISLAND LANGUAGES (31.5%), AND OTHER LANGUAGES (17.4%). PLACE OF BIRTH FOR MISSION HILL'S FOREIGN-BORN POPULATION CHINA: 899; 24.2% SINGAPORE: 70; 1.9% INDIA: 422; 11.4% FRANCE: 66; 1.8% DOMINICAN REPUBLIC: 399; 10.8% CROATIA: 53; 1.4% IRELAND: 168; 4.5% CANADA: 53; 1.4% RUSSIA: 142; 3.8% TRINIDAD & TOBAGO: 51; 1.4% VIETNAM: 138; 3.7% GREECE: 46; 1.2% KOREA: 120; 3.2% JAPAN: 45; 1.2% COLOMBIA: 100; 2.7% JAMAICA: 42; 1.1% ERITREA: 90; 2.4% UZBEKISTAN: 41; 1.1% UKRAINE: 76; 2.0% NICARAGUA: 40; 1.1% FOR MISSION HILL ADULTS OVER THE AGE OF 25 (N=8,014), 18.5% HAVE LESS THAN A HIGH SCHOOL DIPLOMA, 21.7% HAVE A HIGH SCHOOL DEGREE OR GED, 17.4% HAVE SOME COLLEGE OR AN ASSOCIATE'S DEGREE, AND 42.5% HAVE A BACHELOR'S DEGREE OR HIGHER. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. THE PER CAPITA INCOME IN THE PAST 12 MONTHS (IN 2009 INFLATION-ADJUSTED DOLLARS) WAS $24,121. OF THE 7,190 PEOPLE WHO CONSIDER THEMSELVES LABOR FORCE ELIGIBLE, 88.4% ARE EMPLOYED. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. JUST OVER 48% OF MISSION HILL EMPLOYEES HOLD PROFESSIONAL AND MANAGERIAL ROLES. ANOTHER 18.3% ARE IN SERVICE OCCUPATIONS, 23.9% ARE IN SALES AND OFFICE JOBS, AND 9.4% ARE IN A RANGE OF OTHER OCCUPATIONS, INCLUDING CONSTRUCTION, TRANSPORTATION, AND OTHER TYPES OF LABOR. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. IN SUMMARY, MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME RESIDENTS. TO LEARN ABOUT MASS. EYE AND EARS PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MASS. EYE AND EAR CARED FOR 311 PATIENTS WHO LIVE IN MISSION HILL (1.9% OF THE MISSION HILL POPULATION). THE NUMBER OF MISSION HILL RESIDENTS INCREASED SLIGHTLY FROM 2012 (UP 48 FROM 2012'S 263 INDIVIDUALS). WITH THE LONGWOOD FACILITY AND CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THE NUMBER OF MISSION HILL RESIDENTS SERVED BY MASS. EYE AND EAR TO INCREASE OVER TIME. FIGURE BELOW SHOWS THE DEMOGRAPHICS OF MASS. EYE AND EAR'S PATIENTS WHO LIVE IN MISSION HILL. |
| DEMOGRAPHICS OF MASS. EYE AND EAR MISSION HILL PATIENTS (ZIP 02120) N=311 | AGE MEAN 46.5 RANGE 3-95 UNDER 18 (PEDIATRIC) 8 (2.4%) 65+ (GERIATRIC) 69 (22.0%) SEX FEMALE 194 (62.4%) MALE 117 (37.6%) SES (USING PAYER AS PROXY) LOW SES: 89 (28.6%) UN/UNDER-INSURED: 6 (1.9%) RACE/ETHNICITY AMERICAN INDIAN/ALASKA NATIVE: 4 (1.3%) ASIAN: 26 (8.4%) BLACK/AFRICAN AMERICAN: 58 (18.6%) HISPANIC: 48 (15.4%) WHITE: 93 (29.9%%) OTHER: 1 (.3%) NOT AVAILABLE: 81 (26.0%) |
| SCHEDULE H, PART VI, LINE 5 | THE COMMUNITY BENEFITS STRATEGIES MASS. EYE AND EARS COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. HEALTH SCREENING AND DIRECT SERVICES 2. COMMUNITY EDUCATION AND SUPPORT GROUPS 3. ACCESS TO SERVICES/RESOURCES/WORK EXPERIENCE 4. FINANCIAL SUPPORT (GRANTS, DONATIONS, FOUNDATION SUPPORT, SCHOLARSHIPS) CATEGORIES 1 AND 2 DRAW ON MASS. EYE AND EARS BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES AND ALSO INCLUDES INITIATIVES THAT PROVIDE TARGETED POPULATIONS WITH OPPORTUNITIES TO GAIN WORK EXPERIENCE. CATEGORY 4 REPRESENTS MASS. EYE AND EARS OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MASS. EYE AND EAR AND WHO ARE PROVIDING SERVICES TO MASS. EYE AND EARS PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERALS COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR (FY17) FOR EACH STRATEGY IN THE CATEGORY. |
| CATEGORY 1: HEALTH SCREENING AND DIRECT SERVICES | MASS. EYE AND EAR PROVIDES HEALTH SCREENING AND DIRECT CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF VIOLENCE. SPECIFIC INITIATIVES ARE DESCRIBED BELOW. NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS): NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES MORE THAN 400 STUDENTS AND IS ONE OF THE MOST SOUGHT-AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH HIGH SCHOOL FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MASS. EYE AND EARS DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNER WITH NHCSS SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MASS. EYE AND EAR. WORKING WITH NHCS SCHOOL NURSE, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE FOR SCREENING. CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUE SUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS & GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTONS AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MASS. EYE AND EARS EXPERTISE IN VISION SCREENING, LATE BOSTON MAYOR THOMAS MENINO REQUESTED THAT MASS. EYE AND EAR PLAY A ROLE AT CAMP HARBOR VIEW. MASS. EYE AND EAR HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MASS. EYE AND EAR STAFF MEMBERS TRAVEL TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. IN 2017 MASS. EYE AND EAR HELD TWO DAYS OF SCREENING INVOLVING MORE THAN 40 MASS. EYE AND EAR STAFF MEMBERS. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MASS. EYE AND EAR PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MASS. EYE AND EAR STAFF MEMBERS PROVIDE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. UNITED WAY PROJECT HOMELESS CONNECT: MASS. EYE AND EAR SUPPORTED THE INAUGURAL PROGRAM FOR HOMELESS FAMILIES AT THE REGGIE LEWIS CENTER IN ROXBURY. THE MASS. EYE AND EAR TEAM OF VOLUNTEERS OFFERED VISION SCREENINGS AND ARRANGED FOR FOLLOW-UP CARE AS NEEDED. |
| CATEGORY 2: COMMUNITY EDUCATION AND SUPPORT GROUPS | MASS. EYE AND EARS CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS). DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW. PUBLIC FORUM ON THE NOSE AND SINUSES (KNOW YOUR NOSE): THIS YEAR, MEMBERS OF MASS. EYE AND EARS DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON THE NOSE AND SINUSES. TARGETING THE GENERAL PUBLIC, THE EVENT WAS PUBLICIZED VIA DIRECT COMMUNICATION TO MASS. EYE AND EAR PATIENTS (EMAIL INVITATION, DIGITAL SIGNAGE, SOCIAL MEDIA) THE SESSIONS INCLUDED THE NOSE AND SINUSES, MEDICAL TREATMENT OF SINUSITIS, SURGICAL TREATMENT OF SINUSITIS, AND THE BLEEDING NOSE. LOW VISION SUPPORT GROUP: THE LOW VISION SUPPORT GROUP (PART OF MASS. EYE AND EARS VISION REHAB PROGRAM) HELPS PARTICIPANTS UNDERSTAND ISSUES RELATED TO LOW VISION, PROVIDING COPING STRATEGIES FOR DAILY LIVING, PROBLEM-SOLVING TECHNIQUES, AND GOAL-ORIENTED ACTION PLANS. THE GROUP ADDRESSES EMOTIONS EVOKED BY VISION LOSS (E.G., SADNESS/GRIEF, FRUSTRATION, UNCERTAINTY), AS WELL AS HOW TO COMMUNICATE WITH HEALTH CARE PROFESSIONALS, FAMILY, FRIENDS AND STRANGERS. MASS. EYE AND EAR ALSO ARRANGES FOR GUESTS SPEAKERS WHO ARE SPECIALISTS IN SUCH AREAS AS OCCUPATIONAL THERAPY, ORIENTATION AND MOBILITY. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MASS. EYE AND EAR HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. MASS. EYE AND EAR REFERS NEW LARYNGECTOMY PATIENTS TO THE BOSTON CURED CANCER GROUP, HOSTS THE SUPPORT GROUP, AND PROVIDES PARKING. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF-IMAGE. MASS. EYE AND EAR HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MASS. EYE AND EAR PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. HEAR @ BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MASS. EYE AND EAR DONATES MONTHLY MEETING SPACE, AND MASS. EYE AND EAR CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. GRAVES DISEASE/THYROID EYE DISEASE SUPPORT GROUP: MASS. EYE AND EAR OFFERS A THYROID EYE DISEASE (GRAVES DISEASE) SUPPORT GROUP, WHICH ALLOWS MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MASS. EYE AND EAR DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. PHYSICIANS FROM BOTH MASS. EYE AND EAR AND MASS. GENERAL HOSPITAL CONTRIBUTE TO THE PROGRAM. HEALTH FAIRS: MASS. EYE AND EAR STAFF ATTENDED SEVERAL COMMUNITY FAIRS TO EDUCATE THE PUBLIC ABOUT EAR, NOSE, THROAT AND EYE CARE AND ABOUT AVAILABLE HEALTH SERVICE IN VARIOUS COMMUNITIES. THESE INCLUDED: -MISSION HILL HEALTH FAIR -EMERSON HEALTH AND WELLNESS EXPO -STONEHAM TOWN DAY MISSION HILL NEIGHBORHOOD EVENTS: IN 2017, MASS. EYE AND EAR SUPPORTED NUMEROUS EVENTS IN MISSION HILL (IN ADDITION TO INTERNSHIP PROGRAM). THEY INCLUDED INVOLVEMENT WITH THE MISSION HILL MAIN STREETS (HOST AND SPONSOR ANNUAL RECEPTION); INVOLVEMENT WITH YOUTH COLLABORATIVE; SENIOR CELTICS EVENT; MISSION HILL ROAD RACE; WELLNESS LECTURES AT ROXBURY TENANTS OF HARVARD AND SUPPORT AND PARTICIPATION OF EVENTS THERE INCLUDING SENIOR PROM. |
| CATEGORY 3: ACCESS TO SERVICES/RESOURCES/WORK EXPERIENCE | THIS CATEGORY DESCRIBES MASS. EYE AND EAR STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. ALSO INCLUDED HERE ARE ACTIVITIES THAT PROVIDE TARGETED POPULATIONS WITH OPPORTUNITIES TO GAIN WORK EXPERIENCE. TRANSPORTATION FOR NEEDY PATIENTS: MASS. EYE AND EAR PROVIDES FREE TAXI TRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. VOLUNTEER ESCORTS FOR PATIENTS: MASS. EYE AND EAR MANAGES A PROGRAM TO PROVIDE ESCORTS TO PATIENTS WHO NEED ASSISTANCE NAVIGATING THE HOSPITAL AND SURROUNDING AREA. THESE INCLUDE TAXI ESCORTS; ESCORTS TO TRAINS OR BUSES; ESCORTS TO ACCOMMODATIONS; ESCORTS WITHIN HOSPITALS (MASS. EYE AND EAR AND MASS. GENERAL HOSPITAL); AND ASSISTANCE WITH PATIENT MEDICAL PASSPORTS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MASS. EYE AND EAR PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MASS. EYE AND EAR PATIENTS: MASS. EYE AND EARS SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MASS. EYE AND EAR PATIENTS. FREE MEDICATIONS: MASS. EYE AND EARS NEEDY PATIENT FUND COVERS THE COST OF MEDICATIONS FOR PATIENTS WHO CANNOT AFFORD TO PAY. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MASS. EYE AND EARS DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MASS. EYE AND EAR. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITALS FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MASS. EYE AND EARS RESEARCH LIBRARY STAFF REGULARLY ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MASS. EYE AND EAR HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION, TO PATIENTS WITH HEARING LOSS. THESE SERVICES ARE PROVIDED TO PATIENTS AS WELL AS MEMBERS OF THE COMMUNITY THROUGH PARTICIPATION AT LOCAL HEALTH FAIRS AND SCHOOL SCREENINGS. FREE PARKING: MASS. EYE AND EAR OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MASS. EYE AND EAR ALSO EXTENDS FREE PARKING TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR @ BOSTON. PROJECT SEARCH: THIS PROJECT IN PARTNERSHIP WITH THE MASS. COMMISSION FOR THE BLIND AND THE POLUS CENTER FOR SOCIAL AND ECONOMIC DEVELOPMENT CONTINUED IN 2017, PROVIDING INTERNSHIPS FOR INDIVIDUALS WITH VISUAL IMPAIRMENT, AN OPPORTUNITY THAT ALLOWED THEM TO DEVELOP TRANSFERRABLE JOB SKILLS. FENWAY HIGH SCHOOL INTERNSHIP PROGRAM: AS PART OF THE COMMITMENT TO THE MISSION HILL COMMUNITY, MASS. EYE AND EAR PARTNERS WITH FENWAY HIGH SCHOOL (LOCATED IN MISSION HILL) TO PROVIDE A SIX WEEK INTERNSHIP PROGRAM FOR GRADUATING HIGH SCHOOL SENIORS. THEY ARE BASED PRIMARILY AT MASS. EYE AND EAR, LONGWOOD, WHICH IS LOCATED IN THE NEIGHBORHOOD. WE ALSO PARTICIPATE IN THEIR CAREER DAY AT THE SCHOOL, OFFERING MENTORING AND COACHING AS WELL AS FINANCIALLY SUPPORT THEIR ANNUAL FUNDRAISING DINNER. BOSTON CREATES: MASS. EYE AND EAR DEDICATED UNDERUTILIZED SPACE TO BOSTON CREATES, A PROGRAM LAUNCHED UNDER THE LEADERSHIP OF BOSTON MAYOR MARTIN WALSH AND THE OFFICE OF ARTS AND CULTURE. THE PROGRAM IS INTENDED TO PROVIDE FREE SPACE TO HELP RETAIN AND ATTRACT TALENT TO STAY IN BOSTONS VIBRANT ARTS COMMUNITY. TWO LOCAL GROUPS USED THE SPACE IN 2017. CHARITABLE CARE: ADDITIONALLY FOR THIS CATEGORY, MASS. EYE AND EAR PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS FREE OR DISCOUNTED CARE MEETS MASS. EYE AND EARS FINANCIAL ASSISTANCE POLICY. WE MAKE EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR OUR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MASS. EYE AND EAR EXTENDS CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2017 OUR NET CHARITY CARE TOTALED $1,914,478, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MASS. EYE AND EARS FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MASS. EYE AND EARS AND THE COMMUNITY BENEFITS COMMITTEES COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO OUR PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN OUR COMMUNITY BENEFITS PLAN. BELOW, DETAIL RELATED TO THE HOSPITALS NET CHARITY CARE, TOTAL REVENUE, TOTAL PATIENT CARE RELATED EXPENSES, AND BAD DEBT IS PROVIDED. |
| CATEGORY 4: FINANCIAL SUPPORT (GRANTS, DONATIONS, FOUNDATION SUPPORT, | AND SCHOLARSHIPS) MASS. EYE AND EAR DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THAT OF MASS. EYE AND EAR AND WHO SUPPORT THE HOSPITAL'S COMMUNITY BENEFITS GOALS AND ADDRESS ISSUES AFFECTING THE TARGET COMMUNITIES AND PRIORITY POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH. |
| SCHEDULE H, PART VI, LINE 6 | NOT APPLICABLE |
| SCHEDULE H, PART VI, LINE 7 | LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (25 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| BOSTON CHILDREN'S HOSPITAL | |||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | 501(C)(3) | $138,016 | RESEARCH |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| 75 FRANCIS ST | BOSTON | MA | 02115 | 042312909 | 501(C)(3) | $363,401 | RESEARCH |
| JOHNS HOPKINS UNIV SCHOOL OF MEDICINE | |||||||
| 733 N BROADWAY STE 117 | BALTIMORE | MD | 21205 | 521479934 | 501(C)(3) | $14,423 | RESEARCH |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 55 FRUIT ST | BOSTON | MA | 02114 | 042697983 | 501(C)(3) | $803,900 | RESEARCH |
| WORCESTER POLYTECHNIC INSTITUTE | |||||||
| 100 INSTITUTE RD | WORCESTER | MA | 01609 | 042121659 | 501(C)(3) | $36,223 | RESEARCH |
| SCHEPENS EYE RESEARCH INSTITUTE | |||||||
| 20 STANIFORD ST | BOSTON | MA | 02114 | 042129889 | 501(C)(3) | $170,886 | RESEARCH |
| UNIVERSITY OF MIAMI | |||||||
| 1400 NW 10TH AVE | MIAMI | FL | 33136 | 590624458 | 501(C)(3) | $103,172 | RESEARCH |
| MASSACHUSETTS EYE AND EAR ASSOCIATES INC | |||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 222658209 | 501(C)(3) | $14,251,289 | INSTITUTIONAL SUPPORT |
| RHODE ISLAND HOSPITAL | |||||||
| 593 Eddy Street | Providence | RI | 029034923 | 050258954 | 501(c)(3) | $163,380 | RESEARCH |
| CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE | |||||||
| 10900 Euclid Ave | Cleveland | OH | 441067015 | 341018992 | 501(c)(3) | $211,222 | RESEARCH |
| BIONIC EYE TECHNOLOGIES INC | |||||||
| 4 WILLOW LAKE DRIVE | FISHKILL | NY | 12524 | 465766628 | 501(c)(3) | $769,160 | RESEARCH |
| EMORY UNIVERSITY | |||||||
| 1599 CLIFTON ROAD | ATLANTA | GA | 303224250 | 580566256 | 501(c)(3) | $58,598 | RESEARCH |
| PRESIDENT & FELLOWS OF HARVARD | |||||||
| MASSACHUSETTS HALL | CAMBRIDGE | MA | 02138 | 042103580 | 501(c)(3) | $526,306 | RESEARCH |
| MAYO MEDICAL LABRATORIES | |||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | 416011702 | 501(c)(3) | $11,790 | RESEARCH |
| NATIONWIDE CHILDREN'S HOSPITAL | |||||||
| 700 CHILDRENS DRV | COLUMBUS | OH | 432052664 | 316056230 | 501(C)(3) | $28,582 | RESEARCH |
| PORTLAND VA RESEARCH FOUNDATION INC | |||||||
| HOSPITAL ROAD | PORTLAND | OR | 972392964 | 943090170 | 501(C)(3) | $80,315 | RESEARCH |
| UNIVERSITY OF MAINE | |||||||
| 5717 CORBETT HALL | ORONO | ME | 044695717 | 016000769 | 501(c)(3) | $35,263 | RESEARCH |
| UNIVERSITY OF WISCONSIN | |||||||
| 21 NPARK ST | MADISON | WI | 537151218 | 396006492 | 501(c)(3) | $104,175 | RESEARCH |
| WILLS EYE HOSPITAL | |||||||
| 840 WALNUT ST | PHILADELPHIA | PA | 191075109 | 236000204 | 501(c)(3) | $47,528 | RESEARCH |
| DUKE UNIVERSITY | |||||||
| 2200 W MAIN ST | DURHAM | NC | 277054677 | 560532129 | 501(c)(3) | $46,238 | RESEARCH |
| UNIVERSITY OF MICHIGAN | |||||||
| 3003 S STATE ST | ANN ARBOR | MI | 481091287 | 386006309 | 501(c)(3) | $27,787 | RESEARCH |
| UNIVERSITY OF IOWA | |||||||
| 2 GILMORE HALL | IOWA CITY | IA | 522471320 | 426004813 | 501(c)(3) | $59,253 | RESEARCH |
| STANFORD UNIVERSITY | |||||||
| 3160 PORTER DRIVE STE 250 | PALO ALTO | CA | 943041222 | 941156365 | 501(c)(3) | $9,668 | RESEARCH |
| RESEARCH FOUNDATION FOR SUNY | |||||||
| 35 STATE ST | ALBANY | NY | 12207 | 141368361 | 501(c)(3) | $28,296 | RESEARCH |
| WEILL CORNELL MEDICAL COLLEGE | |||||||
| 1300 YORK AVENUE | NEW YORK | NY | 100654805 | 113162397 | 501(c)(3) | $46,589 | RESEARCH |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 25 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE I, PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | SUBRECIPIENT MONITORING POLICY AND PROCEDURES SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE MEEI ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE. RESEARCH ADMINISTRATION ALSO CONDUCTS AN ANNUAL INVENTORY OF INSTITUTIONS TO WHICH RESERACH HAS BEEN SUBAWARDED. A RISK ASSESSMENT MATRIX IS EMPLOYED, ALONG WITH A REVIEW OF THE SUB-RECIPIENTS' MOST RECENT A133 AUDIT REPORT, TO DETERMINE THE LEVEL OF RISK REGARDING THE SUB-RECIPIENTS' ABILITY TO COMPLY WITH FEDERAL GUIDELINES. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (21 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JOHN R FERNANDEZ | ||||||||||||||
| PRESIDENT | $758,265 | $0 | $114,300 | $0 | $142,619 | $0 | $221,901 | $0 | $22,972 | $0 | $1,260,057 | $0 | $120,000 | $0 |
| JOAN W MILLER MD | ||||||||||||||
| DIRECTOR | $0 | $738,539 | $0 | $83,710 | $0 | $20,322 | $0 | $36,475 | $0 | $14,675 | $0 | $893,721 | $0 | $0 |
| MAUREEN KELLEY | ||||||||||||||
| ASST SECRETARY | $190,384 | $0 | $3,500 | $0 | $781 | $0 | $5,916 | $0 | $22,950 | $0 | $223,531 | $0 | $0 | $0 |
| CAROLANN WILLIAMS | ||||||||||||||
| CFO & VP FINANCE AND ADMIN | $419,684 | $0 | $50,592 | $0 | $810 | $0 | $11,311 | $0 | $3,614 | $0 | $486,011 | $0 | $0 | $0 |
| BARBARA J SCULLY | ||||||||||||||
| DIRECTOR PROF REV CYCLE | $181,007 | $0 | $7,000 | $0 | $369 | $0 | $15,474 | $0 | $22,949 | $0 | $226,799 | $0 | $0 | $0 |
| EILEEN O LOWELL | ||||||||||||||
| CNO & VP PAT CARE SVS | $268,352 | $0 | $27,700 | $0 | $2,901 | $0 | $16,459 | $0 | $14,666 | $0 | $330,078 | $0 | $0 | $0 |
| ALAN K LONG | ||||||||||||||
| VP RESEARCH ADMINISTRATION | $155,230 | $0 | $0 | $0 | $136,981 | $0 | $8,994 | $0 | $2 | $0 | $301,207 | $0 | $0 | $0 |
| KENNETH HOLMES | ||||||||||||||
| CFO MEEA | $233,333 | $0 | $26,180 | $0 | $18,480 | $0 | $17,728 | $0 | $22,963 | $0 | $318,684 | $0 | $0 | $0 |
| JEFFREY J PIKE | ||||||||||||||
| CHIEF OPERATING OFFICER | $327,345 | $0 | $33,090 | $0 | $536 | $0 | $12,250 | $0 | $7,098 | $0 | $380,319 | $0 | $0 | $0 |
| JENNIFER STREET | ||||||||||||||
| VP COMMUNICATIONS & PLANNING | $327,481 | $0 | $33,870 | $0 | $1,242 | $0 | $12,725 | $0 | $22,968 | $0 | $398,286 | $0 | $0 | $0 |
| MELISSA M PAUL | ||||||||||||||
| CHIEF DEVELOPMENT OFFICER | $251,196 | $0 | $21,648 | $0 | $18,974 | $0 | $19,957 | $0 | $22,955 | $0 | $334,730 | $0 | $0 | $0 |
| GLENN W BUNTING | ||||||||||||||
| VOICE & SPEECH CLINICAL DIR | $195,063 | $0 | $2,000 | $0 | $4,690 | $0 | $20,424 | $0 | $22,950 | $0 | $245,127 | $0 | $0 | $0 |
| RALPH T PELOSI | ||||||||||||||
| DIRECTOR FACILITIES PLANNING | $180,910 | $0 | $7,500 | $0 | $1,037 | $0 | $9,278 | $0 | $10 | $0 | $198,735 | $0 | $0 | $0 |
| MARTHA PYLE FARRELL | ||||||||||||||
| ASST SECRETARY | $292,606 | $0 | $37,452 | $0 | $20,172 | $0 | $11,789 | $0 | $22,966 | $0 | $384,985 | $0 | $0 | $0 |
| D BRADLEY WELLING | ||||||||||||||
| DIRECTOR | $0 | $988,748 | $0 | $0 | $0 | $18,000 | $0 | $36,475 | $0 | $22,971 | $0 | $1,066,194 | $0 | $0 |
| DEBRA ROGERS | ||||||||||||||
| VP OPHTHALMOLOGY | $234,185 | $0 | $26,010 | $0 | $19,759 | $0 | $10,446 | $0 | $14,664 | $0 | $305,064 | $0 | $0 | $0 |
| RACHEL WASSERSTROM | ||||||||||||||
| VP OTOLARYNGOLOGY | $247,083 | $0 | $26,010 | $0 | $409 | $0 | $10,182 | $0 | $22,961 | $0 | $306,645 | $0 | $0 | $0 |
| MICHAEL RICCI | ||||||||||||||
| CHIEF INFORMATION OFFICER | $221,077 | $0 | $20,000 | $0 | $14,345 | $0 | $10,544 | $0 | $14,656 | $0 | $280,622 | $0 | $0 | $0 |
| DEBORAH L CRONIN-WAELDE | ||||||||||||||
| EXEC DIR AMBULATORY OPERATIONS | $180,969 | $0 | $12,500 | $0 | $371 | $0 | $3,411 | $0 | $11 | $0 | $197,262 | $0 | $0 | $0 |
| LEO J HILL | ||||||||||||||
| DEPUTY CIO | $173,935 | $0 | $15,000 | $0 | $359 | $0 | $3,299 | $0 | $10 | $0 | $192,603 | $0 | $0 | $0 |
| SUNIL EAPPEN MD | ||||||||||||||
| CHIEF MEDICAL OFFICER | $0 | $509,340 | $0 | $53,270 | $0 | $19,242 | $0 | $36,475 | $0 | $22,972 | $0 | $641,299 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE J, PART I, LINE 4A: | IN CONNECTION WITH HIS DEPARTURE, IN OCTOBER 2016 ALAN LONG RECEIVED A PAYMENT OF $110,408 WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III). SCHEDULE J, PART I, LINE 4B: JOHN FERNANDEZ PARTICIPATES IN A DEFERRED COMPENSATION ARRANGEMENT WITH MASSACHUSETTS EYE AND EAR. UNDER THIS AGREEMENT, MR. FERNANDEZ WILL BE CREDITED $200,000 FOR CALENDAR YEAR 2016. EACH ANNUAL CREDIT WILL VEST ON THE FOURTH ANNIVERSARY OF THE DATE SUCH CREDIT WAS MADE OR UPON (1) THE ATTAINMENT OF THE AGE OF 65 WHILE EMPLOYED; (2) TERMINATION WITHOUT CAUSE OR RESIGNATION FOR GOOD REASON; (3) DEATH; (4) DISABILITY; OR (5) CHANGE OF CONTROL OF MASSACHUSETTS EYE AND EAR WITHIN THE MEANING OF SECTION 409A OF THE INTERNAL REVENUE CODE. MR. FERNANDEZ RECEIVED A PAYOUT OF $141,377 FROM THE DEFERRED COMPENSATION AGREEMENT IN 2016. |
| SCHEDULE J, PART I, LINE 7: | THE BOARD OF TRUSTEES OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, UPON RECOMMENDATIONS OF THE COMPENSATION COMMITTEE, APPROVE A BONUS PROGRAM FOR CERTAIN INDIVIDUALS LISTED ON THE SCHEDULE J. THE PROGRAM REQUIRES THAT SUPERVISORY PERSONNEL MAKE THE DETERMINATION OF (1) ELIGIBILITY AND (2) AMOUNT OF BONUS DOLLARS BASED ON OVERALL JOB PERFORMANCE. THE CEO OF THE INFIRMARY HAS THE AUTHORITY TO (1) OVERRULE RECOMMENDATIONS MADE BY SUPERVISORS AND (2) MAKE BONUS DETERMINATIONS FOR VICE PRESIDENT LEVEL PERSONNEL. THE COMPENSATION COMMITTEE OF THE BOARD HAS THE FINAL AUTHORITY FOR BONUSES PAID TO THE CEO AS WELL AS THE VICE PRESIDENTS AND CHIEFS. THE COMPENSATION COMMITTEE MEETING WAS HELD ON NOVEMBER 16, 2016. TOTAL COMPENSATION FOR LISTED INDIVIDUALS, INCLUDING BONUS PAYMENTS, WAS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS, DETERMINED TO BE REASONABLE COMPENSATION, AND APPROVED BY THE BOARD. NO COMPENSATION PAYMENT CAN BE MADE IN EXCESS OF THESE AMOUNTS. |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (2 entries)
| Bond ReferenceBondReferenceCd | Bond Issuer EINBondIssuerEIN | CUSIPCUSIPNum | Bond IssuedBondIssuedDt | Issue PriceIssuePriceAmt | PurposePurposeDesc | DefeasedDefeasedInd | On Behalf Of IssuerOnBehalfOfIssuerInd | Pool FinancingPoolFinancingInd |
|---|---|---|---|---|---|---|---|---|
| MASSACHUSETTS HEALTH AND EDUCATION FACILITIES | ||||||||
| A | 042456011 | 57586EWL1 | 2010-09-29 | $63,156,092 | FACILITY IMPROVEMENTS | false | false | false |
| MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | ||||||||
| B | 043431814 | 000000000 | 2015-12-30 | $70,394,000 | REFNDNG(2010)&FACILITY IMPROVEMNTS | false | false | false |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (2 entries)
| Bond ReferenceBondReferenceCd | RetiredRetiredAmt | Bond DefeasedBondDefeasedAmt | Total ProceedsTotalProceedsAmt | In Reserve FundInReserveFundAmt | Capitalized InterestCapitalizedInterestAmt | Refunding EscrowRefundingEscrowAmt | Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt | Credit EnhancementCreditEnhancementAmt | Working Capital ExpendituresWorkingCapitalExpendituresAmt | Capital ExpendituresCapitalExpendituresAmt | Other Spent ProceedsOtherSpentProceedsAmt | UnspentUnspentAmt | Substantial CompletionSubstantialCompletionYr | Current RefundingCurrentRefundingInd | Advance RefundingAdvanceRefundingInd | Final Allocation MadeFinalAllocationMadeInd | Adequate Books And Rec MaintAdequateBooksAndRecMaintInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | $6,980,000 | $0 | $63,156,092 | $5,006,994 | $5,191,181 | $0 | $1,243,623 | $0 | $0 | $51,707,858 | $0 | $0 | 2015 | false | false | Yes (true) | Yes (true) |
| B | $779,547 | $0 | $70,394,000 | $0 | $0 | $0 | $441,892 | $0 | $0 | $29,916,662 | $15,079,333 | $24,956,113 | Yes (true) | false | false | Yes (true) |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (2 entries)
| Bond ReferenceBondReferenceCd | Owning Bond Financed PropertyOwningBondFinancedPropertyInd | Any Lease ArrangementsAnyLeaseArrangementsInd | Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd | Any Research AgreementsAnyResearchAgreementsInd | Private Bus Use By OthersPrivateBusUseByOthersPct | Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd | Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd |
|---|---|---|---|---|---|---|---|
| A | false | false | false | false | 0 | false | Yes (true) |
| B | false | false | false | false | 0 | false | Yes (true) |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (2 entries)
| Bond ReferenceBondReferenceCd | Form8038 T FiledForm8038TFiledInd | No Rebate DueNoRebateDueInd | Variable Rate IssueVariableRateIssueInd | Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd | Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd | Business Name Line1GICProviderName/BusinessNameLine1Txt | Gross Proceeds InvestedGrossProceedsInvestedInd | Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd | Rebate Not Due YetRebateNotDueYetInd | Term Of HedgeTermOfHedgePct | Superintegrated HedgeSuperintegratedHedgeInd | Hedge TerminatedHedgeTerminatedInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ||||||||||||
| A | false | Yes (true) | false | false | false | 0 | false | false | ||||
| CITIZENS BANK | ||||||||||||
| B | false | Yes (true) | Yes (true) | false | 0 | false | false | Yes (true) | 10. | false | false | |
Procedures Corrective Action ProceduresCorrectiveActionGrp (2 entries)
| Bond ReferenceBondReferenceCd | Procedures Corrective ActionProceduresCorrectiveActionInd |
|---|---|
| A | Yes (true) |
| B | Yes (true) |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, BOND (A), COLUMN (F): | THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS. |
| PART IV, BOND (A), LINE 2C: | A REBATE CALCULATION WAS PERFORMED FOR THE BONDS ON OCTOBER 13, 2015 FOR THE REBATE PERIOD ENDED SEPTEMBER 30, 2016. NO ARBITRAGE REBATE WAS DUE. |
Schedule L IRS990ScheduleL
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $0 | TotalBalanceDueAmt |
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| JOAN MILLER MD | |||
| DRCTR IS LICENSOR TO ORG | $202,762 | PATENT LICENSE PROCEEDS | false |
| SALLY REILEY | |||
| DAUGHTER OF DIRECTOR | $21,342 | ANNUAL SALARY | false |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS | FormAndLineReferenceDesc |
| Explanation | (A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (11 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990 PART I, LINE 1 & PART III, LINE 1 | THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI"). FORM 990, PART III, LINE 4A: MASSACHUSETTS EYE AND EAR IS A SPECIALTY HOSPITAL DEDICATED TO EXCELLENCE IN THE CARE OF DISORDERS THAT AFFECT THE EYE, EAR, NOSE, THROAT AND ADJACENT REGIONS OF THE HEAD AND NECK. IN THE 2017-2018 BEST HOSPITALS SURVEY, U.S. NEWS & WORLD REPORT RANKED MASS. EYE AND EAR #2 IN THE NATION FOR EAR, NOSE AND THROAT CARE AND #4 FOR EYE CARE. THE COMMITMENT TO PROVIDE COMPASSIONATE AND ACCESSIBLE PATIENT CARE CONTINUED IN 2017 WITH THE EXPANSION TO NINETEEN CLINICAL CARE LOCATIONS. A MAJOR FOCUS OF THE ORGANIZATION OVER THE PAST YEAR WAS THE PROCESS TO BECOME A MEMBER OF PARTNERS HEALTHCARE. THE GOAL IS FOR MASS. EYE AND EAR TO BECOME A TIER 1 ENTITY WITHIN THE TOP HEALTHCARE ORGANIZATION IN THE NORTHEAST. MASS. EYE AND EAR AND PARTNERS HAVE A LONG HISTORY OF COLLABORATION AND THE HOPE IS THAT THIS WILL ALLOW FOR A MORE SEAMLESS SHARING OF SOME OF THE CENTRALIZED SERVICES PARTNERS EXTENDS TO ITS ENTITIES, INCLUDING PEOPLESOFT (ENTERPRISE RESOURCE PLANNING) AND EPIC (UNIFIED PATIENT CARE SYSTEM). THE PROCESS, NEARING A FINAL VOTE (AS OF THIS WRITING) WILL ENABLE MASS. EYE AND EAR TO MAINTAIN ITS OWN HOSPITAL LICENSE, BOARD OF DIRECTORS AND INDEPENDENT DEPARTMENTS, WITH THE SUPPORT OF PARTNERS HEALTHCARE. CLINICAL HIGHLIGHTS DEPARTMENT OF OPHTHALMOLOGY FACULTY HIRES MARY E. ARONOW, MD EMMA DAVIES, MD THADDEUS DRYJA, MD (PART-TIME) ROSARIO FERNANDEZ-GODINO, PHD, MSC GABRIEL FICKETT, OD ZHIGANG HE, PHD JOHN KEMPEN, MD, MPH, MHS, PHD FRANCOIS LEBRETON, PHD MICHAEL PRICE, MD SHRINIVAS PUNDLIK, PHD JANE SCHWEITZER, MD AYELLET SEGR, MSC, PHD DAVID SOL - DEL VALLE, MD TOMASZ STRYJEWSKI, MD JO-ANN HANEY TILTON, MD JIA YIN, MD FACULTY APPOINTMENTS OPHTHALMOLOGY ALEX BOWERS, PHD: ASSOCIATE PROFESSOR OF OPHTHALMOLOGY SUNIL CHAUHAN, PHD: ASSOCIATE PROFESSOR OF OPHTHALMOLOGY JOSEPH CIOLINO, MD: ASSOCIATE PROFESSOR OF OPHTHALMOLOGY JACK GREINER, DO, OD, PHD: ASSISTANT PROFESSOR OF OPHTHALMOLOGY (PART-TIME) XIAOQING GUO, MD: INSTRUCTOR IN OPHTHALMOLOGY NAHYOUNG GRACE LEE, MD: ASSISTANT PROFESSOR OF OPHTHALMOLOGY HEITIAN LEI, PHD: ASSISTANT PROFESSOR OF OPHTHALMOLOGY YANG LIU, MD: INSTRUCTOR IN OPHTHALMOLOGY RICHARD MASLAND, PHD: DISTINGUISHED DAVID GLENDENNING COGAN PROFESSOR OF OPHTHALMOLOGY JOAN W. MILLER, MD: DAVID GLENDENNING COGAN PROFESSOR OF OPHTHALMOLOGY ERIC PIERCE, MD, PHD: SOLMAN AND LIBE FRIEDMAN PROFESSOR OF OPHTHALMOLOGY SHIVAKUMAR VASANTH, PHD: INSTRUCTOR IN OPHTHALMOLOGY DEPARTMENT OF OTOLARYNGOLOGY NEW RECRUITS FULL-TIME MEDICAL STAFF KEVIN H. FRANCK, PHD, MBA, CCC-A KENNETH M. GRUNDFAST, MD, FACS YUNA C. LARRABEE, MD COMMUNITY-BASED MEDICAL STAFF CHRISTINA V. SCIRICA, MD SEAN T. DOHERTY, MD, FACS JORDAN GLICKSMAN, MD, MPH JONG CHUL PARK, MD (PART-TIME MASS. EYE AND EAR) OTOLARYNGOLOGY FACULTY APPOINTMENTS PROFESSOR GREGORY W. RANDOLPH, MD, FACS, FACE ASSOCIATE PROFESSOR BENJAMIN S. BLEIER, MD ERIC H. HOLBROOK, MD HIDEKO HEIDI NAKAJIMA, MD, PHD JEREMY D. RICHMON, MD ASSISTANT PROFESSOR NATE JOWETT, MD, FRCSC DAVID H. JUNG, MD, PHD FELIPE SANTOS, MD OTHER PROMOTIONS/NEW LEADERSHIP BENJAMIN S. BLEIER, MD, WAS NAMED THE DIRECTOR OF ENDOSCOPIC SKULL BASE SURGERY. STACEY T. GRAY, MD, WAS APPOINTED PRESIDENT OF THE OTOLARYNGOLOGY MEDICAL STAFF. RICHARD F. LEWIS, MD, WAS APPOINTED DIRECTOR OF THE JENKS VESTIBULAR PHYSIOLOGY LABORATORY. DANIEL B. POLLEY, PHD, WAS APPOINTED THE DIRECTOR OF THE LAUER TINNITUS RESEARCH CENTER. MEAGHAN REED, AUD, WAS PROMOTED TO ASSOCIATE DIRECTOR OF AUDIOLOGY. PHILLIP C. SONG, MD, WAS APPOINTED CHIEF OF THE LARYNGOLOGY DIVISION. DEPARTMENT OF ANESTHESIOLOGY - NEW RECRUITS JEREMY JUANG, MD- STAFF ANESTHESIOLOGIST MATTHEW NOVAK, MD- PEDIATRIC STAFF ANESTHESIOLOGIST NINA NAMI, MD- PEDIATRIC STAFF ANESTHESIOLOGIST NAILA MOGHUL, MD- STAFF ANESTHESIOLOGIST GUSTAVO LOZADA, MD- STAFF ANESTHESIOLOGIST YANA LEVIN, MD- STAFF ANESTHESIOLOGIST GENEVIEVE GALUTERA, CRNA REBECCA VIGIL, CRNA BRENDAN MCBRINE, ANESTHESIA TECHNICIAN SHAKERIA MATTIER, EXECUTIVE ASSISTANT FACULTY PROMOTIONS MAKARA CAYER, MD ASSISTANT ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR STEPHEN CAMPO, MD ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR MARTHA CORDOBA-AMOROCHO, MD ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR AREZOU GOLI, MD ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR MARTIN JOSEPH R. HORTALEZA, MD ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR GUSTAVO LOZADA, MD- ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR CO- DIRECTOR OF AMBULATORY ANESTHESIA, MASS. EYE AND EAR ALVARO MACIAS, MD ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR; ASSOCIATE ANESTHESIA DIRECTOR OF THE OPERATING ROOMS, MASS. EYE AND EAR DONGDONG YAO, MD ASSOCIATE ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR ARSHAD RAGEN, MD ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR JEREMY W. GOLDFARB, MD ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR LISA M. HAMMOND, MD ANESTHESIOLOGIST, ACTIVE STAFF, MASS. EYE AND EAR DEPARTMENT OF RADIOLOGY NO NEW RECRUITS IN FY17 FOR FY17, THE DEPARTMENT OF RADIOLOGY HAD A TOTAL OF 141 RESIDENT AND FELLOW ROTATIONS JOINING DR. CURTIN AND FACULTY FOR DAILY READ OUT SESSIONS AND HEAD AND NECK IMAGING TRAINING (58 FROM MGH, 59 FROM BWH, AND 24 FROM BIDMC). |
| RESEARCH | DEPARTMENT OF OPHTHALMOLOGY AMD CENTER OF EXCELLENCE RESEARCHERS IDENTIFY POTENTIAL BIOMARKERS OF AGE-RELATED MACULAR DEGENERATION A STUDY BY AUTHORS INCLUDING JOAN W. MILLER, MD, INES LAINS, MD, DEEBA HUSAIN, MD, JOHN B. MILLER, MD, DEMETRIOS G. VAVVAS, MD, PHD, AND IVANA K. KIM, MD, FOUND THAT PATIENTS WITH ANY STAGE OF AGE-RELATED MACULAR DEGENERATION (AMD) CARRY SIGNS OF THE DISEASE IN THEIR BLOOD THAT MAY BE FOUND THROUGH SPECIAL LABORATORY TESTS. THE STUDY DESCRIBES A NEW TECHNIQUE KNOWN AS METABOLOMICS, WHICH CAN IDENTIFY BLOOD PROFILES ASSOCIATED WITH AMD - THE LEADING CAUSE OF ADULT BLINDNESS IN DEVELOPED COUNTRIES - AND ITS LEVEL OF SEVERITY. THESE POTENTIAL LIPID BIOMARKERS IN HUMAN BLOOD PLASMA MAY LEAD TO EARLIER DIAGNOSIS, BETTER PROGNOSTIC INFORMATION, AND MORE PRECISE TREATMENT OF PATIENTS WITH AMD, AS WELL AS POTENTIAL NEW TARGETS FOR AMD TREATMENT. RESEARCHERS IDENTIFY KEY COMPOUNDS TO RESOLVE ABNORMAL VASCULAR GROWTH IN AGE-RELATED MACULAR DEGENERATION A STUDY LED BY KIP CONNOR, PHD, SHOWED THAT A COMPOUND OF SPECIFIC BIOACTIVE PRODUCTS FROM A MAJOR FAMILY OF ENZYMES REDUCED THE SEVERITY OF AGE-RELATED MACULAR DEGENERATION (AMD) IN A PRECLINICAL MODEL. THE REPORT SUGGESTS THAT IT MAY BE POSSIBLE TO PREVENT THE VISION LOSS RESULTING FROM DISEASE-CAUSING ANGIOGENESIS AND INFLAMMATION OBSERVED IN WET AMD BY INCREASING THE EXPRESSION OF SPECIFIC BIOACTIVE LIPID METABOLITES IN THE RETINA. THE RESEARCH DEMONSTRATES THAT THESE BIOACTIVE LIPIDS HAVE THE ABILITY TO REGULATE INFLAMMATORY IMMUNE CELLS IN THE RETINA, KEY REGULATORS OF THE ANGIOGENIC PROCESS IN THIS DISEASE. GIVEN THIS, THESE MOLECULES SHOW PROMISING THERAPEUTIC POTENTIAL NOT ONLY FOR AMD, BUT ALSO FOR OTHER MAJOR CONDITIONS THAT INVOLVE ANGIOGENESIS AND INFLAMMATION, SUCH AS CARDIOVASCULAR DISEASE AND CANCER. CHOROIDAL CHANGES ASSOCIATED WITH SUBRETINAL DRUSENOID DEPOSITS IN AGE-RELATED MACULAR DEGENERATION USING SWEPT-SOURCE OCT JOHN B. MILLER, MD, INES LAINS, MD, AND COLLEAGUES IDENTIFIED A REDUCTION IN CHOROIDAL THICKNESS AND VESSEL VOLUME IN SUBJECTS WITH INTERMEDIATE AGE-RELATED MACULAR GENERATION (AMD) WHEN SUBRETINAL DRUSENOID DEPOSITS WERE PRESENT - AN IMPORTANT CLINICAL FEATURE OF AMD. UNDERSTANDING CHOROIDAL ABNORMALITIES MAY SHED LIGHT UPON THE DEVELOPMENT OF SUBRETINAL DRUSENOID DEPOSITS AND PROVIDE INSIGHT INTO THE PATHOGENESIS OF AMD. CORNEA CENTER OF EXCELLENCE NEW TECHNIQUE MAY PREVENT GRAFT REJECTION IN HIGH-RISK CORNEAL TRANSPLANT PATIENTS REZA DANA, MD, MSC, MPH, AND RESEARCHERS DEVELOPED A NOVEL STRATEGY TO PROMOTE THE TOLERANCE OF CORNEAL TRANSPLANTS IN PATIENTS AT HIGH RISK FOR REJECTION. THEY TARGETED ANTIGEN-PRESENTING CELLS IN DONOR TISSUES WITH A COMBINATION OF TWO CYTOKINES, TGF-? AND IL-10, THAT WORK TOGETHER TO PROMOTE TOLERANCE OF THE GRAFT BY THE TRANSPLANT RECIPIENT'S IMMUNE SYSTEM. RESTORATION OF CORNEAL TRANSPARENCY BY MESENCHYMAL STEM CELLS A STUDY LED BY SUNIL CHAUHAN, PHD, IDENTIFIED HEPATOCYTE GROWTH FACTOR (HGF), SECRETED BY MESENCHYMAL STEM CELLS, AS THE KEY FACTOR RESPONSIBLE FOR RESTORING CORNEAL TRANSPARENCY AND PROMOTING WOUND HEALING IN PRECLINICAL MODELS OF CORNEAL INJURY. THE FINDINGS SUGGEST THAT HGF-BASED TREATMENTS MAY BE EFFECTIVE IN RESTORING VISION IN PATIENTS WITH SEVERELY SCARRED CORNEAS. TRANSLATIONAL RESEARCH ON LUBRICIN DEMONSTRATES SIGNIFICANT IMPROVEMENT OF MULTIPLE SIGNS AND SYMPTOMS OF DRY EYE DISEASE DAVID A. SULLIVAN, PHD, IN COLLABORATION WITH COLLEAGUES FROM SEVERAL INSTITUTIONS WORLDWIDE, EVALUATED THE USE OF RECOMBINANT HUMAN LUBRICIN AS A TREATMENT FOR PATIENTS WITH DRY EYE DISEASE. A CLINICAL TRIAL BASED ON THIS RESEARCH SHOWED SIGNIFICANT IMPROVEMENT IN SIGNS AND SYMPTOMS OF DRY EYE DISEASE COMPARED TO SODIUM HYALURONATE WITHOUT ADVERSE EVENTS DURING THE INVESTIGATION. RESEARCHERS FIND STEM CELLS IN NORMAL AND FUCHS CORNEAL ENDOTHELIUM ULA JURKUNAS, MD, WAS THE PRINCIPAL INVESTIGATOR OF A STUDY THAT, FOR THE FIRST TIME, IDENTIFIED STEM CELLS NOT ONLY IN NORMAL CORNEAL ENDOTHELIUM BUT ALSO IN CORNEAL ENDOTHELIUM OF PATIENTS WITH FUCHS' ENDOTHELIAL CORNEAL DYSTROPHY (FECD). CORNEAL TRANSPLANTATION IS THE ONLY CURRENTLY ACCEPTED THERAPY FOR FECD. THIS FINDING HOLDS PROMISE FOR NEW THERAPIES TO BE DEVELOPED THAT POSSIBLY PROMOTE THE DIVISION OF PATIENTS' OWN STEM CELLS AND ALLOW THE CORNEA TO CLEAR WITHOUT A NEED FOR CORNEAL TRANSPLANTATION IN FECD PATIENTS. DETERMINANTS OF OCULAR PAIN SEVERITY IN PATIENTS WITH DRY EYE DISEASE REZA DANA, MD, MSC, MPH, AND COLLEAGUES PUBLISHED A PAPER THAT SHOWED THE SEVERITY OF OCULAR PAIN IN DRY EYE DISEASE CORRELATES WITH NON-OCULAR COMORBIDITIES, SUCH AS USE OF ANTI-DEPRESSANTS, RATHER THAN WITH CLINICAL SIGNS OF SURFACE DISEASE. DIABETIC EYE DISEASE CENTER OF EXCELLENCE RESEARCHERS IDENTIFY NEW TARGET FOR ABNORMAL BLOOD VESSEL GROWTH IN THE EYES A TEAM LED JOSEPH F. ARBOLEDA-VELASQUEZ, MD, PHD, AND LEO A. KIM, MD, PHD, IDENTIFIED A NOVEL THERAPEUTIC TARGET FOR RETINAL NEOVASCULARIZATION, OR ABNORMAL BLOOD VESSEL GROWTH IN THE RETINA, A HALLMARK OF ADVANCED DIABETIC EYE DISEASE (PROLIFERATIVE DIABETIC RETINOPATHY). ACCORDING TO THE REPORT, THE TRANSCRIPTION FACTOR RUNX1 WAS FOUND IN ABNORMAL RETINAL BLOOD VESSELS, AND BY INHIBITING RUNX1 WITH A SMALL MOLECULE DRUG, THE RESEARCHERS ACHIEVED A 50 PERCENT REDUCTION OF RETINOPATHY IN PRECLINICAL MODELS. THESE FINDINGS PAVE THE WAY FOR NEW THERAPIES THAT ADDRESS DIABETIC RETINOPATHY AND OTHER CONDITIONS INVOLVING ABNORMAL VESSEL GROWTH WITHIN THE RETINA. GLAUCOMA CENTER OF EXCELLENCE DRUG-DISPENSING CONTACT LENS LOWERS EYE PRESSURE IN PRECLINICAL STUDY IN A PRECLINICAL MODEL FOR GLAUCOMA, JOSEPH CIOLINO, MD, AND COLLEAGUES DEMONSTRATED THAT A NOVEL DRUG-DISPENSING CONTACT LENS IS AT LEAST AS EFFECTIVE, AND POSSIBLY MORE SO, AS DAILY LATANOPROST EYE DROPS. CONTACT LENSES HAVE BEEN STUDIED AS A MEANS OF OCULAR DRUG DELIVERY FOR NEARLY 50 YEARS, YET MANY SUCH LENSES ARE INEFFECTIVE BECAUSE THEY DISPENSE THE DRUG TOO QUICKLY. THE CONTACT LENSES USED IN THIS STUDY RELEASED THE DRUG GRADUALLY BECAUSE A THIN FILM OF DRUG-ENCAPSULATED POLYMERS WAS ADDED TO THE PERIPHERY OF THE LENS. PREVIOUSLY, THE RESEARCHERS SHOWED THAT THE LENS IS CAPABLE OF DELIVERING MEDICATION IN VIVO CONTINUOUSLY FOR ONE MONTH. BECAUSE THE DRUG FILM IS CONFINED TO THE LENS PERIPHERY, THE CENTER REMAINS CLEAR, ALLOWING FOR NORMAL VISUAL ACUITY, BREATHABILITY, AND HYDRATION. THE LENSES CAN BE MADE WITH OR WITHOUT REFRACTIVE POWER. INFECTIOUS DISEASE INSTITUTE ANTIBIOTIC-RESISTANT MICROBES DATE BACK 450 MILLION YEARS MICHAEL GILMORE, PHD, FRANCOIS LEBRETON, PHD, AND COLLEAGUES HAVE SHED LIGHT ON THE EVOLUTIONARY HISTORY OF ENTEROCOCCI, BACTERIA WHICH EVOLVED NEARLY INDESTRUCTIBLE PROPERTIES AND HAVE BECOME LEADING CAUSES OF MODERN ANTIBIOTIC-RESISTANT INFECTIONS IN HOSPITALS. ACCORDING TO THEIR STUDY, ENTEROCOCCI AROSE FROM AN ANCESTOR THAT DATES BACK 450 MILLION YEARS - ABOUT THE TIME WHEN ANIMALS WERE FIRST CRAWLING ONTO LAND (AND WELL BEFORE THE AGE OF DINOSAURS). RESEARCHERS IDENTIFY NEW ANTIBIOTIC- AND IMMUNE-RESISTANT BACTERIUM, DEVELOP TEST TO LIMIT SPREAD RESEARCHERS LED BY MICHAEL GILMORE, PHD, DISCOVERED A NEW MUTATION IN A HIGHLY ANTIBIOTIC-RESISTANT STRAIN OF E. COLI THAT INHIBITS INFECTION-FIGHTING WHITE BLOOD CELLS. THE RESEARCHERS DESCRIBED A PATIENT WHO WAS DIAGNOSED WITH A SEVERE CORNEAL INFECTION. THE UNDERLYING BACTERIUM WAS DETERMINED TO BE ESBL E. COLI, A TYPE OF MICROBE KNOWN TO BE RESISTANT TO A WIDE RANGE OF ANTIBIOTICS. THE PATIENT WAS TREATED WITH TWO ANTIBIOTIC EYE DROPS-TO WHICH THE MICROBE WAS STILL SENSITIVE-AND THE EYE INFECTION RESOLVED. USING STATE-OF-THE-ART GENOMICS SEQUENCING TECHNIQUES IN THE OCULAR GENOMICS INSTITUTE, THE RESEARCH TEAM FOUND THAT THE AGGRESSIVE MICROBE HAD A NEW MUTATION, TERMED ST131. MOBILITY ENHANCEMENT AND VISION REHABILITATION CENTER OF EXCELLENCE NEW GLASSES MAY HELP MINIMIZE PERIPHERAL VISION LOSS VISION SCIENTISTS MAY HAVE DISCOVERED HOW TO REDUCE PEDESTRIAN COLLISIONS IN CROWDED AND CHAOTIC OPEN SPACE ENVIRONMENTS LIKE BUS TERMINALS, SHOPPING MALLS AND CITY PLAZAS INVOLVING INDIVIDUALS WITH PARTIAL BLINDNESS. RESEARCHERS LED BY ELI PELI, MSC, OD, DETERMINED FROM WHICH DIRECTION COLLISIONS WITH PARTIALLY BLIND PEDESTRIANS ARE MOST LIKELY TO ORIGINATE. THEY CREATED A MATHEMATICAL MODEL TO DETERMINE COLLISION RISK AND COMPARED THAT RISK TO THE LIMITED VISION OF 42 PATIENTS WITH RETINITIS PIGMENTOSA. THIS UNDERSTANDING WILL GUIDE THE DEVELOPMENT OF NEW GLASSES THAT EXPAND THE SIGHT OF A PERSON WITH LIMITED PERIPHERAL VISION. |
| OCULAR GENOMICS INSTITUTE | COPY-NUMBER VARIATION IS AN IMPORTANT CONTRIBUTOR TO THE GENETIC CAUSALITY OF INHERITED RETINAL DEGENERATIONS GENE THERAPY SHOWS PROMISE FOR TREATING SOME FORMS OF INHERITED RETINAL DEGENERATION (IRD), BUT FOR ABOUT 40% OF PATIENTS WITH IRD-RELATED VISION LOSS, THE GENETIC CAUSE IS UNKNOWN. A TEAM LED BY ERIC A. PIERCE, MD, PHD, AND KINGA BUJAKOWSKA, PHD, REPORTED THAT COPY NUMBER VARIATIONS ARE TO BLAME, IN PART, WITH MOST DELETIONS OCCURRING THROUGH NON-ALLELIC HOMOLOGOUS RECOMBINATION (NAHR). THE TEAM MAPPED NAHR-PRONE REGIONS WITH OVERLAPPING IRD GENES AND SUGGESTED THAT EXTENDING THE SEARCH TO THESE REGIONS AND OTHER STRUCTURAL VARIATIONS MAY REVEAL MORE GENETIC CAUSALITY AND SPEED DIAGNOSIS FOR PATIENTS. OTHER RESEARCH GENOME EDITING WITH CRISPR-CAS9 PREVENTS ANGIOGENESIS OF THE RETINA A RESEARCH TEAM LED BY HETIAN LEI, PHD, SUCCESSFULLY PREVENTED MICE FROM DEVELOPING ANGIOGENESIS OF THE RETINA-THE SENSORY TISSUE AT THE BACK OF THE EYE-USING GENE-EDITING TECHNIQUES WITH CRISPR-CAS9. ANGIOGENESIS CAUSES VISION LOSS AND BLINDNESS AND IS A FEATURE OF SEVERAL DEGENERATIVE EYE CONDITIONS, INCLUDING PROLIFERATIVE DIABETIC RETINOPATHY (PDR), WET AGE-RELATED MACULAR DEGENERATION (AMD), AND RETINOPATHY OF PREMATURITY (ROP). THE RESEARCHERS PRESENTED A NOVEL GENE-EDITING TECHNIQUE TO PREVENT RETINAL ANGIOGENESIS, WHICH COULD LEAD TO THE DEVELOPMENT OF NEW THERAPIES FOR EYE CONDITIONS MARKED BY PATHOLOGICAL INTRAOCULAR ANGIOGENESIS. SYSTEMIC THERAPY OUTPERFORMS INTRAOCULAR IMPLANT FOR TREATING UVEITIS JOHN KEMPEN, MD, MPH, MHS, PHD, AND COLLEAGUES WORKED ON A SEVEN-YEAR, MULTI-CENTER CLINICAL TRIAL FUNDED BY THE NATIONAL EYE INSTITUTE, IN WHICH THEY FOUND THAT SYSTEMIC THERAPY CONSISTING OF CORTICOSTEROIDS AND IMMUNOSUPPRESSANTS PRESERVED VISION OF UVEITIS PATIENTS BETTER - AND HAD FEWER ADVERSE OUTCOMES - THAN A LONG-LASTING CORTICOSTEROID INTRAOCULAR IMPLANT. AFTER SEVEN YEARS, VISUAL ACUITY ON AVERAGE REMAINED STABLE AMONG PARTICIPANTS ON SYSTEMIC THERAPY BUT DECLINED BY AN AVERAGE OF SIX LETTERS (ABOUT ONE LINE ON AN EYE CHART) AMONG PARTICIPANTS WHO HAD THE IMPLANT. RESEARCHERS IDENTIFY MECHANISM OF RETINA DAMAGE FOLLOWING CHEMICAL EYE BURNS ELEFTHERIOS PASCHALIS, PHD, LED A RESEARCH TEAM THAT HAS IDENTIFIED AN INFLAMMATORY FACTOR, TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA), AS THE MECHANISM RESPONSIBLE FOR CAUSING RETINAL DAMAGE FROM ALKALI EYE BURNS. THIS FINDING MAY LEAD TO THE DEVELOPMENT OF THERAPIES THAT PREVENT DAMAGE TO THE RETINA. CHEMICAL EYE BURNS CAUSED BY ALKALI AGENTS NOT ONLY INJURE THE FRONT OF THE EYE - THE CORNEA, WHERE THE CONTACT TAKES PLACE - BUT ALSO CAUSE WIDESPREAD DAMAGE TO THE LIGHT-SENSITIVE TISSUE AT THE BACK OF THE EYE (THE RETINA) AS WELL, OFTEN LEADING TO OPTIC NERVE DAMAGE AND GLAUCOMA. RESEARCHERS IDENTIFY FACTORS RESPONSIBLE FOR CHRONIC NATURE OF AUTOIMMUNE DISEASE RESEARCHERS LED BY REZA DANA, MD, MSC, MPH, HAVE UNCOVERED TWO FACTORS RESPONSIBLE FOR THE CHRONIC, LIFELONG NATURE OF AUTOIMMUNE DISORDERS, WHICH TEND TO FLARE UP INTERMITTENTLY IN AFFECTED PATIENTS. THESE TWO FACTORS ARE CELL-SIGNALING PROTEINS CALLED CYTOKINES-SPECIFICALLY INTERLEUKIN-7 AND -15 (IL-7 AND IL-15)-THAT ARE SECRETED BY CELLS OF THE IMMUNE SYSTEM AND HELP MODULATE MEMORY TH17 CELLS, A SUBSET OF T CELLS WHICH ARE KNOWN TO CONTRIBUTE TO AUTOIMMUNE DISORDERS. UNTIL NOW, IT WAS UNCLEAR HOW TH17 CELLS MAINTAINED MEMORY; THE STUDY RESULTS SHOW THAT IL-7 AND IL-15 SIGNAL THE TH17 CELLS TO CHRONICALLY RESIDE IN THE BODY. THESE FINDINGS MAY LEAD TO THE DEVELOPMENT OF NEW THERAPIES TO ADDRESS A VARIETY OF CHRONIC AUTOIMMUNE DISORDERS. DEPARTMENT OF OTOLARYNGOLOGY RESEARCH FACULTY ARTUR A. INDZHYKULIAN, MD, PHD KRISTINA SIMONYAN, MD, PHD, DR. MED. ANNE E. TAKESIAN, PHD BASIC SCIENCE GENE THERAPY RESTORES HEARING IN DEAF MICE DOWN TO A WHISPER EFFORTS TO DEVELOP GENE THERAPIES FOR HEARING LOSS HAVE BEEN HAMPERED BY THE LACK OF SAFE, EFFICIENT, AND CLINICALLY RELEVANT DELIVERY MODALITIES. IN A STUDY LED BY LUKAS LANDEGGER, MD, PHD, AND KONSTANTINA M. STANKOVIC, MD, PHD, FACS, RESEARCHERS DEMONSTRATED THE SAFETY AND EFFICIENCY OF ANC80L65, A RATIONALLY DESIGNED SYNTHETIC VECTOR, FOR TRANSGENE DELIVERY TO THE MOUSE COCHLEA. EX VIVO TRANSDUCTION OF MOUSE ORGANOTYPIC EXPLANTS IDENTIFIED ANC80L65 FROM A SET OF OTHER ADENO-ASSOCIATED VIRUS (AAV) VECTORS AS A POTENT VECTOR FOR THE COCHLEAR CELL TARGETS. ROUND WINDOW MEMBRANE INJECTION RESULTED IN HIGHLY EFFICIENT TRANSDUCTION OF INNER AND OUTER HAIR CELLS IN MICE. THE ABILITY OF ANC80L65 TO TARGET OUTER HAIR CELLS AT HIGH RATES, A REQUIREMENT FOR RESTORATION OF COMPLEX AUDITORY FUNCTION, MAY ENABLE FUTURE GENE THERAPIES FOR HEARING AND BALANCE DISORDERS. LANDEGGER LD, PAN B, ASKEW C, WASSMER SJ, GLUCK SD, GALVIN A, TAYLOR R, FORGE A, STANKOVIC KM, HOLT JR, VANDENBERGHE LH. A SYNTHETIC AAV VECTOR ENABLES SAFE AND EFFICIENT GENE TRANSFER TO THE MAMMALIAN INNER EAR. NAT BIOTECHNOL. 2017 MAR;35(3):280284. NEW TECHNIQUE GENERATES HIGH VOLUME OF SENSORY CELLS NEEDED FOR HEARING THE DEATH OF COCHLEAR HAIR CELLS, WHICH DO NOT REGENERATE, IS A CAUSE OF HEARING LOSS IN A HIGH PERCENTAGE OF THE POPULATION. IN 2013, MASS. EYE AND EAR RESEARCHERS SUCCESSFULLY REGENERATED HAIR CELLS AND RESTORED PARTIAL HEARING IN MICE BY CONVERTING CELLS FOUND IN THE INNER EAR INTO HAIR CELLS. HOWEVER, THE SUCCESS OF THIS APPROACH WAS LIMITED BY THE SMALL NUMBER OF CELLS THAT COULD BE TURNED INTO HAIR CELLS. IN A STUDY PUBLISHED IN CELL REPORTS, A TEAM LED BY ALBERT EDGE, PHD, SHOWED THAT LGR5+ CELLS CAN BE AUGMENTED TO A MUCH HIGHER VOLUME AND THEN CONVERTED INTO HAIR CELLS, LENDING HOPE THAT FULL HEARING CAN BE RESTORED TO THOSE WITH HEARING LOSS DUE TO DAMAGED HAIR CELLS. FROM A SINGLE MOUSE, THE TEAM GENERATED MORE THAN 11,500 HAIR CELLS (COMPARED TO LESS THAN 200 HAIR CELLS GENERATED WITHOUT EFFORTS TO AUGMENT). TARGETING SUPPORTING CELLS CAPABLE OF PROLIFERATION AND COCHLEAR HAIR CELL REPLACEMENT COULD LEAD TO THE DISCOVERY OF HEARING LOSS TREATMENTS. MCLEAN WJ, YIN X, LU L, LENZ DR, MCLEAN D, LANGER R, KARP JM, EDGE AS. CLONAL EXPANSION OF LGR5-POSITIVE CELLS FROM MAMMALIAN COCHLEA AND HIGH-PURITY GENERATION OF SENSORY HAIR CELLS. CELL REP. 2017 FEB 21;18(8):19171929. FAST-SPIKING GABA CIRCUIT DYNAMICS IN THE AUDITORY CORTEX PREDICT RECOVERY OF SENSORY PROCESSING FOLLOWING PERIPHERAL NERVE DAMAGE HEARING ABILITIES VARY WIDELY AFTER SELECTIVE DAMAGE TO INNER HAIR CELLS OR AUDITORY NERVE FIBERS. TO ADDRESS HOW THESE PLASTICITY PROCESSES ARE COORDINATED OVER THE COURSE OF FUNCTIONAL RECOVERY, JENNIFER RESNIK, PHD, AND DANIEL B. POLLEY, PHD, FROM THE EATON-PEABODY LABORATORIES, INDUCED EITHER A MODERATE OR MASSIVE LOSS OF COCHLEAR AFFERENT SYNAPSES IN ADULT MICE AND TRACKED THE DAY-BY-DAY RECOVERY OF SOUND PROCESSING IN THE AUDITORY CORTEX. IN DOING SO, THE RESEARCHERS DEVELOPED A NEW APPROACH TO RECORD FROM INDIVIDUAL NEURONS OVER A SEVERAL MONTH PERIOD WHILE MONITORING DYNAMIC CHANGES IN THE STRENGTH OF INHIBITION FROM A SELECT CLASS OF FAST-SPIKING PARVALBUMIN-CONTAINING INHIBITORY CELLS. RESNIK J, POLLEY DB. FAST-SPIKING GABA CIRCUIT DYNAMICS IN THE AUDITORY CORTEX PREDICT RECOVERY OF SENSORY PROCESSING FOLLOWING PERIPHERAL NERVE DAMAGE. ELIFE. 2017 MAR 21;6. IDENTIFICATION OF INDUCED AND NATURALLY OCCURRING CONDUCTIVE HEARING LOSS IN MICE USING BONE CONDUCTION A SIGNIFICANT FRACTION OF THE GENETIC DEFECTS IN MOUSE MODELS OF HEARING LOSS AFFECTS BOTH THE INNER AND MIDDLE EAR. A COMMON METHOD USED TO SEPARATE SENSORY-NEURAL FROM CONDUCTIVE PATHOLOGIES IN THE HEARING CLINIC IS THE COMBINATION OF AIR-CONDUCTION AND BONE-CONDUCTION AUDIOMETRY. A TEAM OF RESEARCHERS FROM THE EATON-PEABODY LABORATORIES AT MASS. EYE AND EAR/HARVARD MEDICAL SCHOOL, INCLUDING JOHN J. ROSOWSKI, PHD, DESCRIBED A NEW TECHNIQUE TO MEASURE AIR- AND BONE-CONDUCTED HEARING RESPONSES IN MICE AND USE THEM TO SEPARATE CONDUCTIVE AND SENSORY-NEURAL LOSSES. THEY STIMULATED THE MOUSE EAR BOTH ACOUSTICALLY AND VIA WHOLE-HEAD VIBRATION TO DEMONSTRATE THE PRESENCE OF AN AGE-RELATED CONDUCTIVE HEARING LOSS IN A COMMON MOUSE MODEL OF PRESBYCUSIS, THE BALB/C MOUSE. CHHAN D, MCKINNON ML, ROSOWSKI JJ. IDENTIFICATION OF INDUCED AND NATURALLY OCCURRING CONDUCTIVE HEARING LOSS IN MICE USING BONE CONDUCTION. HEAR RES. 2017 MAR;346:4554. |
| ATTENUATING THE EAR CANAL FEEDBACK PRESSURE OF A LASER-DRIVEN | HEARING AID MICROPHONE PLACEMENT BEHIND THE PINNA, WHICH MINIMIZES FEEDBACK BUT ALSO REDUCES PERCEPTION OF THE HIGH-FREQUENCY PINNA CUES NEEDED FOR SOUND LOCALIZATION, IS ONE REASON WHY HEARING-AID USERS OFTEN COMPLAIN ABOUT THE POOR SOUND QUALITY AND DIFFICULTY UNDERSTANDING SPEECH IN NOISY SITUATIONS. MASS. EYE AND EAR/HARVARD MEDICAL SCHOOL RESEARCHER SUNIL PURIA, PHD, IN COLLABORATION WITH EARLENS CORPORATION, INVESTIGATED STRATEGIES FOR MINIMIZING THE FEEDBACK PRESSURE AND DEVELOPED FINITE ELEMENT MODELS OF THE HUMAN MIDDLE EAR USING STAPES VELOCITY, COCHLEAR PRESSURE, EAR CANAL IMPEDANCE, AND MIDDLE EAR POWER REFLECTANCE FROM LIVING AND CADAVER TEMPORAL BONES. THESE MODELS HAVE APPLICATIONS IN THE DESIGN OF IMPROVED HEARING AIDS THAT MECHANICALLY DRIVE THE UMBO (THE CENTRAL, MOST INVERTED PORTION OF THE EAR DRUM). SUCH DESIGN APPLICATIONS COULD REDUCE FEEDBACK PRESSURE USING ACOUSTIC DAMPERS IN THE CANAL TIP. THIS NEW DESIGN PAVES THE PATH TOWARDS PLACING THE MICROPHONES OF FUTURE DEVICES THAT MECHANICALLY SIMULATE THE MIDDLE EAR IN THE EAR CANAL. KHALEGHIA M, PURIA S. ATTENUATING THE EAR CANAL FEEDBACK PRESSURE OF A LASER-DRIVEN HEARING AID. J ACOUST SOC OF AM. 2017;141:3,16831693. CONNECTOME-WIDE PHENOTYPICAL AND GENOTYPICAL ASSOCIATIONS IN FOCAL DYSTONIA LARYNGEAL DYSTONIA (LD), OR SPASMODIC DYSPHONIA, IS A MOVEMENT DISORDER THAT SELECTIVELY AFFECTS THE PRODUCTION OF SPEECH DUE TO IMPAIRED VOLUNTARY CONTROL OF VOCAL FOLD MOVEMENTS. EARLY STUDIES HAVE POINTED TO SEGREGATED CHANGES IN BRAIN ACTIVITY AND CONNECTIVITY AND ONLY RECENTLY, THE NOTION THAT DYSTONIA PATHOPHYSIOLOGY MAY LIE IN ABNORMALITIES OF LARGE-SCALE BRAIN NETWORKS HAS APPEARED IN THE LITERATURE. IN SUPPORT OF THIS EMERGING VIEW, A TEAM OF RESEARCHERS INCLUDING KRISTINA SIMONYAN, MD, PHD, CONDUCTED DETAILED INVESTIGATION OF THE ARCHITECTURE OF LARGE-SCALE FUNCTIONAL BRAIN NETWORKS IN A UNIQUELY LARGE POPULATION OF 90 LD PATIENTS AND 32 HEALTHY SUBJECTS. THEIR FINDINGS PROVIDE THE FIRST COMPREHENSIVE ATLAS OF FUNCTIONAL TOPOLOGY ACROSS DIFFERENT PHENOTYPES AND GENOTYPES OF FOCAL DYSTONIA. AS SUCH, THIS STUDY CONSTITUTES AN IMPORTANT PARADIGM-SHIFTING STEP TOWARDS DEFINING DYSTONIA AS A LARGE-SCALE NETWORK DISORDER FOR UNDERSTANDING OF ITS CAUSATIVE PATHOPHYSIOLOGY AND THE IDENTIFICATION OF DISORDER-SPECIFIC MARKERS. FUERTINGER S, SIMONYAN K. CONNECTOME-WIDE PHENOTYPICAL AND GENOTYPICAL ASSOCIATIONS IN FOCAL DYSTONIA. J NEUROSCI. 2017 AUG 2;37(31):74387449. HISTOPATHOLOGY HISTOPATHOLOGY OF THE HUMAN INNER EAR IN COGANS SYNDROME WITH COCHLEAR IMPLANTATION COGAN SYNDROME IS A RARE DISORDER CHARACTERIZED BY NON-SYPHILITIC INTERSTITIAL KERATITIS AND AUDIOVESTIBULAR SYMPTOMS WITH PROFOUND SENSORINEURAL HEARING LOSS REPORTED IN APPROXIMATELY 50 PERCENT OF PATIENTS WITH THIS DISORDER, OFTEN RESULTING IN CANDIDACY FOR COCHLEAR IMPLANTATION. A TEAM OF RESEARCHERS INCLUDING JOESPH B. NADOL, JR., MD, RECENTLY COMPLETED A STUDY THAT BECAME THE FIRST HISTOPATHOLOGIC REPORT OF A PATIENT WITH COGANS SYNDROME WHO, DURING LIFE, HAD UNDERGONE BILATERAL COCHLEAR IMPLANTATION. ALTHOUGH SEVERE BILATERAL DEGENERATION OF THE SPIRAL GANGLION NEURONS WAS SEEN, THE POSTOPERATIVE WORD DISCRIMINATION SCORE WAS BETWEEN 50 AND 60 PERCENT BILATERALLY. THE HISTOPATHOLOGY SEEN WITHIN THE INNER EAR WAS THE RESULT OF LABYRINTHITIS SECONDARY TO COGANS SYNDROME IN ADDITION TO THE IMMUNE-MEDIATED RESPONSE TO THE IMPLANTATION PROCESS. KAMAKURA T, LEE DJ, HERRMANN BS, NADOL JB JR. HISTOPATHOLOGY OF THE HUMAN INNER EAR IN THE COGAN SYNDROME WITH COCHLEAR IMPLANTATION. AUDIOL NEUROOTOL. 2017;22(2):116123. CLINICAL PRACTICE PATIENTS WITH SEVERE CHRONIC RHINOSINUSITIS SHOW IMPROVEMENT WITH VERAPAMIL TREATMENT A CLINICAL TRIAL STUDYING THE USE OF VERAPAMIL, A DRUG CURRENTLY IN USE FOR CARDIOVASCULAR DISEASE AND CLUSTER HEADACHE, IN ALLEVIATING CHRONIC RHINOSINUSITIS (CRS) WITH NASAL POLYPS REVEALED SIGNIFICANT IMPROVEMENT IN THE SYMPTOMS OF THIS SUBSET OF PATIENTS. LED BY BENJAMIN S. BLEIER, MD, IT IS THE FIRST STUDY OF ITS KIND TO EXPLORE TREATMENT FOR CRS BY INHIBITING P-GLYCOPROTEIN, A PROTEIN PUMP WITHIN THE NASAL LINING THAT MASS. EYE AND EAR RESEARCHERS PREVIOUSLY IDENTIFIED AS A MECHANISM FOR THESE SEVERE CASES OF CRS MARKED BY THE PRESENCE OF NASAL POLYPS. THE CLINICAL TRIAL RESULTS, WHICH ARE PUBLISHED IN THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE, SUGGEST THAT VERAPAMIL REPRESENTS A PROMISING NOVEL THERAPY FOR THE TREATMENT OF CRS WITH NASAL POLYPS. MIYAKE MM, NOCERA A, LEVESQUE P, GUO R, FINN CA, GOLDFARB J, GRAY S, HOLBROOK E, BUSABA N, DOLCI JE, BLEIER BS. DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL OF VERAPAMIL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. J ALLERGY CLIN IMMUNOL. 2017 JAN 11. TREATMENT DISPARITIES IN THE MANAGEMENT OF EPISTAXIS IN UNITED STATES EMERGENCY DEPARTMENTS WITH LIMITED DATA ON EPISTAXIS PRESENTATION AND MANAGEMENT PATTERNS IN UNITED STATES EMERGENCY DEPARTMENTS (EDS), A TEAM OF RESEARCHERS INCLUDING STACEY T. GRAY, MD, AND ROSH SETHI, MD, MPH, AIMED TO CHARACTERIZE PATIENTS WHO PRESENT TO THE ED WITH EPISTAXIS AND IDENTIFY FACTORS ASSOCIATED WITH NASAL-PACKING USE. THEY STUDIED US ED EPISTAXIS PRESENTATION AND MANAGEMENT PATTERNS USING A NATIONAL DATABASE. IN THEIR ANALYSIS OF MORE THAN ONE MILLION ED VISITS FOR EPISTAXIS, THEY FOUND THAT 19.7 PERCENT OF PATIENTS RECEIVE NASAL PACKING. THEY ALSO IDENTIFIED SEVERAL FACTORS ASSOCIATED WITH PACKING UTILIZATION, INCLUDING LOWER SOCIOECONOMIC STATUS, GEOGRAPHIC LOCATION, HOSPITAL TRAUMA DESIGNATION, SEASONALITY, AND MEDICAL CO-MORBIDITIES. THEIR RESULTS REVEALED POTENTIAL DISPARITIES IN PACKING UTILIZATION THAT MAY IMPACT PATIENT MORBIDITY AND INCREASE HEALTHCARE COSTS. SETHI RKV, KOZIN ED, ABT NB, BERGMARK R, GRAY ST. TREATMENT DISPARITIES IN THE MANAGEMENT OF EPISTAXIS IN UNITED STATES EMERGENCY DEPARTMENTS. LARYNGOSCOPE. 2017 JUL 8. CLINICALLY SIGNIFICANT IMPROVEMENTS FOLLOWING FUNCTIONAL SEPTORHINOPLASTY DETECTED WITH GLOBAL HEALTH-RELATED QUALITY-OF-LIFE INSTRUMENT NASAL AIRWAY OBSTRUCTION IS A COMMON PRESENTING COMPLAINT AMONG PATIENTS IN OTOLARYNGOLOGY PRACTICES, AND ITS TREATMENT NECESSITATES CRITICAL OUTCOMES EVALUATION AND COST-UTILITY ANALYSIS. A TEAM OF RESEARCHERS INCLUDING ROBIN W. LINDSAY, MD, EVALUATED THE UTILITY AND APPLICABILITY OF THE EUROQOL 5-DIMENSION (EQ5D) GLOBAL HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) QUESTIONNAIRE FOR THE ASSESSMENT OF CLINICAL OUTCOMES IN FUNCTIONAL SEPTORHINOPLASTY AND FOUND THAT NASAL OBSTRUCTION IMPACTS BOTH DISEASE-SPECIFIC AND GLOBAL QUALITY OF LIFE. A TOTAL OF 135 PATIENTS COMPLETED THE EQ5D AND NOSE SURVEYS PREOPERATIVELY AND POSTOPERATIVELY. OF THESE, 117 COMPLETED THE TWO-MONTH SURVEY AND 64 COMPLETED THEIR LAST SURVEY AT SIX OR MORE MONTHS. OVERALL, THE NASAL VALVE CORRECTION IMPROVED NOT ONLY DISEASE-SPECIFIC QUALITY OF LIFE BUT ALSO GLOBAL HRQOL. THE ABILITY TO CALCULATE HEALTH UTILITY VALUES FROM THE EQ5D AND ITS LOW RESPONSE BURDEN MAKE IT AN ATTRACTIVE TOOL FOR SEPTORHINOPLASTY OUTCOMES RESEARCH. FULLER JC, LEVESQUE PA, LINDSAY R. ASSESSMENT OF THE EUROQOL 5-DIMENSION QUESTIONNAIRE FOR DETECTION OF CLINICALLY SIGNIFICANT GLOBAL HEALTH-RELATED QUALITY-OF-LIFE IMPROVEMENT FOLLOWING FUNCTIONAL SEPTORHINOPLASTY. JAMA FACIAL PLAST SURG. 2017 MAR 1;19(2):95100. A MOTION SICKNESS DRUG WORSENS VESTIBULAR PERCEPTION DESPITE THE VESTIBULAR CONTRIBUTION TO MOTION SICKNESS, LITTLE IS KNOWN ABOUT HOW MOTION SICKNESS DRUGS MODIFY THE PERCEPTION OF VESTIBULAR STIMULI. A TEAM OF RESEARCHERS INCLUDING FAISAL KARMALI, PHD, STUDIED HOW ORAL PROMETHAZINE (BRAND NAME PHENERGAN) MODIFIES VESTIBULAR PERCEPTUAL THRESHOLDS. THESE THRESHOLDS MEASURE THE SMALLEST MOTION THAT CAN BE RELIABLY PERCEIVED AND HAVE BEEN SHOWN TO BE A SENSITIVE MEASURE OF VESTIBULAR PRECISION. IN THIS TEST, SUBJECTS SIT IN A CHAIR AND REPEATEDLY EXPERIENCE SMALL MOTIONS TO THE LEFT OR RIGHT, AND REPORT THEIR PERCEPTION OF THE DIRECTION OF EACH MOTION. THE RESEARCHERS FOUND THAT TILT THRESHOLDS INCREASED 31 PERCENT AFTER INGESTION OF PROMETHAZINE, INDICATING A WORSENING OF VESTIBULAR PERCEPTION. THESE RESULTS COULD HAVE IMPORTANT FUNCTIONAL IMPLICATIONS SINCE RECENT STUDIES SHOW THAT HIGHER TILT THRESHOLDS ARE ASSOCIATED BOTH WITH A HIGHER RISK OF FAILING A BALANCE TEST AND WORSENING PERFORMANCE IN A PILOTING TASK. DIAZ ARTILES A, PRIESOL AJ, CLARK TC, SHERWOOD D, OMAN CM, YOUNG LR, KARMALI F. THE IMPACT OF ORAL PROMETHAZINE ON HUMAN WHOLE-BODY MOTION PERCEPTUAL THRESHOLDS. J. ASSOC. RES. OTOLARYNGOL. 2017. ACCEPTED. |
| DURATION OF ANALGESIC USE AND RISK OF HEARING LOSS IN WOMEN | ASPIRIN, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), AND ACETAMINOPHEN ARE THE MOST COMMONLY USED MEDICATIONS IN THE US. FREQUENT USE OF ANALGESICS HAS BEEN ASSOCIATED WITH HIGHER RISK OF HEARING LOSS. HOWEVER, THE ASSOCIATION BETWEEN DURATION OF ANALGESIC USE AND RISK OF HEARING LOSS IS UNCLEAR. THEREFORE, A TEAM OF RESEARCHERS INCLUDING BRIAN M. LIN, MD, PROSPECTIVELY INVESTIGATED THE RELATION BETWEEN DURATION OF ANALGESIC USE AND SELF-REPORTED HEARING LOSS AMONG 55,850 WOMEN IN THE NURSES HEALTH STUDY. THEY FOUND THAT LONGER DURATION OF NSAID USE WAS ASSOCIATED WITH A TEN PERCENT INCREASE IN RISK OF HEARING AND LONGER DURATION OF ACETAMINOPHEN USE WAS ASSOCIATED WITH A NINE PERCENT INCREASE IN RISK OF HEARING LOSS. DURATION OF ASPIRIN USE WAS NOT ASSOCIATED WITH HEARING LOSS. CONSIDERING THE HIGH PREVALENCE OF ANALGESIC USE AND THE HIGH PROBABILITY OF FREQUENT AND/OR PROLONGED EXPOSURE IN WOMEN OF MORE ADVANCED AGES, OUR FINDINGS SUGGEST NSAID USE AND ACETAMINOPHEN USE MAY BE MODIFIABLE RISK FACTORS FOR HEARING LOSS. LIN BM, CURHAN SG, WANG M, EAVEY R, STANKOVIC KM, CURHAN GC. DURATION OF ANALGESIC USE AND RISK OF HEARING LOSS IN WOMEN. AM J EPIDEMIOL. 2017 JAN 1. 185(1):4047. PATIENTS WITH DEPRESSION SYMPTOMS DUE TO CHRONIC SINUS DISEASE MAY BE LESS PRODUCTIVE DEPRESSED PATIENTS WITH CHRONIC RHINOSINUSITIS (CRS) ARE MORE LIKELY TO MISS DAYS OF WORK OR SCHOOL THAN THOSE WITHOUT DEPRESSION SYMPTOMS, ACCORDING TO THE RESULTS OF A STUDY LED BY AHMAD R. SEDAGHAT, MD, PHD. THE FINDINGS, PUBLISHED IN ANNALS OF ALLERGY, ASTHMA AND IMMUNOLOGY, IDENTIFY DEPRESSION SYMPTOMS AS THE PRIMARY DRIVER OF LOST DAYS OF PRODUCTIVITY IN PATIENTS WITH CRS. IN SEARCH OF AN ASSOCIATION WITH LOST PRODUCTIVITY, THE RESEARCHERS ASSESSED THE MAIN SYMPTOMS OF CRS-DISTURBANCES OF SLEEP, NASAL OBSTRUCTION, EAR AND FACIAL PAIN, AND EMOTIONAL FUNCTION-IN 107 PATIENTS USING A STANDARDIZED SURVEY. ON AVERAGE, STUDY PARTICIPANTS REPORTED THREE MISSED DAYS OF WORK OR SCHOOL IN A THREE-MONTH PERIOD, OR 12 MISSED DAYS IN A YEAR. WHEN THE RESEARCHERS TOOK A CLOSER LOOK AT THE SURVEYS, THEY IDENTIFIED EMOTIONAL SYMPTOMS, IN WHICH DEPRESSION SYMPTOMS ARE THE STRONGEST FEATURE, AS THE PRIMARY DRIVER OF MISSED DAYS OF WORK OR SCHOOL. CAMPBELL AP, PHILLIPS KM, HOEHLE LP, FENG AL, BERGMARK RW, CARADONNA DS, GRAY ST, SEDAGHAT AR. DEPRESSION SYMPTOMS AND LOST PRODUCTIVITY IN CHRONIC RHINOSINUSITIS. ANN ALLERGY ASTHMA IMMUNOL. 2017 MAR;118(3):286289. GLOBAL SURGERY EFFECT OF REMOVING THE BARRIER OF TRANSPORTATION COSTS ON SURGICAL UTILISATION EIGHTY-ONE MILLION PEOPLE FACE IMPOVERISHMENT FROM SURGICAL COSTS EVERY YEAR. THE MAJORITY OF THIS IMPOVERISHMENT IS ATTRIBUTABLE TO THE NON-MEDICAL COSTS OF CARE SUCH AS TRANSPORTATION, FOOD, AND LODGING. OF THESE, TRANSPORTATION IS THE LARGEST, BUT BECAUSE IT IS NOT VIEWED AS AN ACTUAL MEDICAL COST, IT IS FREQUENTLY UNADDRESSED. IN A STUDY LED BY MARK G. SHRIME, MD, MPH, PHD, FACS, RESEARCHERS EXAMINED THE BARRIER THAT TRANSPORTATION COSTS RAISE TO ACCESSING SURGERY IN LOW-INCOME COUNTRIES. THE RESEARCHERS USED DATA OVER FOUR YEARS FROM MERCY SHIPS, AN ORGANIZATION THAT DELIVERS FREE SPECIALIZED SURGICAL CARE IN SUB-SAHARAN AFRICA. OVER THESE FOUR YEARS, THE SHIP WAS DOCKED IN THREE COUNTRIES (GUINEA, REPUBLIC OF CONGO, AND MADAGASCAR) AND SAW 4,340 SURGICAL PATIENTS, 2,629 OF WHOM LIVED FURTHER THAN FIVE HOURS AWAY. THEY FOUND THAT WHEN CONTROLLING FOR ALL POSSIBLE CONFOUNDERS, THE NO-SHOW RATE DROPPED BY NEARLY HALF WHEN TRANSPORTATION WAS PAID FOR. THIS HIGHLIGHTS THAT DECREASING DEMAND-SIDE BARRIERS TO SURGICAL CARE CANNOT BE LIMITED ONLY TO THE REMOVAL OF USER FEES. SHRIME MG, HAMER M, MUKHOPADHYAY S, KUNZ LM, CLAUS NH, RANDALL K, JEAN-BAPTISTE JH, MAEVATOMBO PH, TOH MPS, BIDDELL JR, BOS R, WHITE M. EFFECT OF REMOVING THE BARRIER OF TRANSPORTATION COSTS ON SURGICAL UTILISATION IN GUINEA, MADAGASCAR, AND THE REPUBLIC OF CONGO. BMJ GLOB HEALTH 2017;2:E000434. DOI:10.1136/ BMJGH-2017-000434. RADIOLOGY DR. AMY JULIANO CONTINUES TO WORK NIH GRANT AS CO-INVESTIGATOR: EXTRAORALLY DELIVERED LOW LEVEL LIGHT THERAPY FOR PREVENTION OF OROPHARYNGEAL MUCOSITIS IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: SPONSOR NAME: NATIONAL INSTITUTES OF HEALTH; PRINCIPAL INVESTIGATOR: NATHANIEL TREISTER, DMD, DMSC. THIS IS A JOINT PROJECT WITH BWH, DFCI AND THE UNIVERSITY OF MASSACHUSETTS, LOWELL. |
| FORM 990, PART III, LINE 4B | EDUCATION ENT EDUCATION HIGHLIGHTS THIS YEAR WE CELEBRATED THE GRADUATION OF THE CLASS OF 2017 AT A JUNE 23RD CEREMONY HELD IN THE MELTZER AUDITORIUM AT MASS. EYE AND EAR. OUR GRADUATES INCLUDED FRANCIS PETE X. CREIGHTON, JR., MD, REBECCA J. HAMMON, MD, TAHA A. JAN, MD, MATTHEW R. NAUNHEIM, MD, MBA, AND GEORGE A. SCANGAS, MD. WE ALSO CELEBRATED THE GRADUATION OF FIVE CLINICAL FELLOWS: REGAN W. BERGMARK, MD, RHINOLOGY ADAM P. CAMPBELL, MD, RHINOLOGY CALLUM FARIS, MD, FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY RUWAN KIRINGODA, MD, NEUROTOLOGY HEATHER A. OSBORN, MD, FRCSC, HEAD AND NECK SURGICAL ONCOLOGY/MICROVASCULAR SURGERY FOLLOWING GRADUATION, WE WELCOMED SEVERAL NEW TRAINEES IN OTOLARYNGOLOGY TO MASS. EYE AND EAR, INCLUDING FIVE NEW OTOLARYNGOLOGY INTERNS AND EIGHT CLINICAL FELLOWS. OUR OTOLARYNGOLOGY INTERNS INCLUDE ERIC R. BARBARITE, MD, ADEEB DERAKHSHAN, MD, KRUPA R. PATEL, MD, TIFFANY V. WANG, MD, AND PHOEBE KUO YU, MD. OUR CLINICAL FELLOWS INCLUDE JOSEPH R. DUSSELDORP, MD (FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY), JACQUELINE J. GREENE, MD (FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY), JOSEPH ZENGA, MD (HEAD AND NECK ONCOLOGY/ MICROVASCULAR SURGERY), NICHOLAS A. DEWYER, MD (NEURTOLOGY), SARAH BOUHABEL, MD (PEDIATRIC OTOLARYNGOLOGY), EDWARD T. EL RASSI, MD (RHINOLOGY), GEORGE A. SCANGAS, MD (RHINOLOGY), AND MOHAMED SHAMA, MD (THYROID AND PARATHYROID SURGERY). IN OTHER EDUCATION NEWS, WE CONTINUE TO ENJOY OUR STATE-OF-THE-ART OTOLARYNGOLOGY SURGICAL TRAINING LABORATORY AND HAVE HELD SEVERAL MAJOR COURSES THERE OVER THE PAST YEAR, FROM RESIDENT DISSECTION COURSES TO CME COURSES WITH INTERNATIONAL ATTENDEES. THIS YEAR, TWO NEW LECTURESHIPS WERE ESTABLISHED, INCLUDING THE DONALD G. KEAMY, SR., LECTURESHIP AND THE C.T. LEE ENDOWED LECTURESHIP IN SPIRITUALITY, COMPASSION, AND HEALING. AWARDS AND HONORS OPHTHALMOLOGY TERESA CHEN, MD: A. CLIFFORD BARGER EXCELLENCE IN MENTORING AWARD, HARVARD MEDICAL SCHOOL KIP CONNOR, PHD: YOUNG MENTOR AWARD, HARVARD MEDICAL SCHOOL PATRICIA D'AMORE, PHD, MBA: PRESIDENT-ELECT, ASSOCIATION OF UNIVERSITY PROFESSORS OF OPHTHALMOLOGY RESEARCH DIRECTORS COUNCIL REZA DANA, MD, MSC, MPH: 2018 FRIEDENWALD AWARD, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY; 2017 SENIOR ACHIEVEMENT AWARD, AMERICAN ACADEMY OF OPHTHALMOLOGY DEAN ELIOTT, MD: LIFETIME MENTORSHIP AWARD, VIT-BUCKLE SOCIETY EVANGELOS GRAGOUDAS, MD: 2017 SIMMONS LESSELL EXCELLENCE IN EDUCATION AWARD, DEPARTMENT OF OPHTHALMOLOGY, MASS. EYE AND EAR, HARVARD MEDICAL SCHOOL KATHRYN HATCH, MD: NAMED AN OUTSTANDING FEMALE LEADER IN OPHTHALMOLOGY BY MILLENIALEYE JAE-HYUN JUNG, PHD: 2017 ALICE J. ADLER FELLOWSHIP OF SCHEPENS EYE RESEARCH INSTITUTE OF MASS. EYE AND EAR, ELEANOR AND MILES SHORE 50TH ANNIVERSARY FELLOWSHIP, HARVARD MEDICAL SCHOOL FREDERICK JAKOBIEC, MD, DSC: MERRILL REEH PRIZE FROM THE AMERICAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY ULA JURKUNAS, MD: 2017 PFIZER OPHTHALMICS CARL CAMRAS TRANSLATIONAL RESEARCH AWARD CAROLYN KLOEK, MD: 2017 EDUCATOR AWARD, WOMEN IN OPHTHALMOLOGY GANG LUO, PHD: INNOVATIONS IN TECHNOLOGY LOW VISION RESEARCH AWARD, RESEARCH TO PREVENT BLINDNESS/READER'S DIGEST PARTNERS FOR SIGHT FOUNDATION/CONSUMER TECHNOLOGY ASSOCIATION FOUNDATION JOAN W. MILLER, MD: INDUCTED INTO THE DOWLING SOCIETY, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY; APPOINTED TO THE BOARD OF TRUSTEES, ASSOCIATION FOR UNIVERSITY PROFESSORS IN OPHTHALMOLOGY LOUIS PASQUALE, MD: 2017 GOLD FELLOW, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY ELI PELI, MSC, OD: CHARLES F. PRENTICE MEDAL AWARD, AMERICAN ACADEMY OF OPTOMETRY ROBERTO PINEDA II, MD: ACCEPTED INTO THE INTERNATIONAL INTRAOCULAR IMPLANT CLUB BRIAN SONG, MD, MPH: JOANNE ANGLE INVESTIGATOR AWARD, PREVENT BLINDNESS DAVID SULLIVAN, MS, PHD: DR. DONALD R. KORB AWARD, AMERICAN OPTOMETRIC ASSOCIATION CONTACT LENS AND CORNEA SECTION LUK VANDENBERGHE, PHD: NELSON TRUST AWARD, RESEARCH TO PREVENT BLINDNESS; 2017 ED GOLLOB BOARD OF DIRECTORS' AWARD, FOUNDATION FIGHTING BLINDNESS AMY WATTS, OD: 2016 NORMAN KNIGHT LEADERSHIP AWARD IN OPHTHALMOLOGY DAVID WU, MD, PHD: 2017 ELEANOR AND MILES SHORE 50TH ANNIVERSARY FELLOWSHIP; IRATY AWARD FOR RESEARCH IN RETINAL DISEASES MICHAEL YOUNG, PHD: 2017 SILVER FELLOW, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY OTOLARYNGOLOGY BENJAMIN S. BLEIER, MD, RECEIVED THE TOP SCIENCE ABSTRACT COHORT FROM THE AMERICAN RHINOLOGIC SOCIETY. JEAN M. BRUCH, DMD, MD, CELEBRATED THE RELEASE OF THE SECOND EDITION OF CLINICAL ORAL MEDICINE AND PATHOLOGY. DANIEL G. DESCHLER, MD, FACS, IS THE PRESIDENT-ELECT FOR THE NEW ENGLAND OTOLARYNGOLOGICAL SOCIETY AND RECEIVED A NOMINATION FOR THE 2017 EXCELLENCE IN MENTORING AWARDS GIVEN BY HARVARD MEDICAL SCHOOL. STACEY T. GRAY, MD, IS THE CHAIR OF THE OTOLARYNGOLOGY PROGRAM DIRECTORS ORGANIZATION. JOHN J. GUINAN, JR., PHD, WAS HONORED AT THE 2017 MECHANICS OF HEARING INTERNATIONAL MEETING, WHICH WAS CO-CHAIRED BY SUNIL PURIA, PHD. ELLIOTT D. KOZIN, MD, WAS ELECTED TO THE NATIONAL RESIDENT MATCHING PROGRAM BOARD OF DIRECTORS AND IS A 2017 STAR REVIEWER FOR OTOLARYNGOLOGY-HEAD AND NECK SURGERY. SHARON G. KUJAWA, PHD, RECEIVED THE BIENNIAL CALLIER PRIZE IN COMMUNICATION DISORDERS. DANIEL J. LEE, MD, FACS, SUNIL PURIA, PHD, HIDEKO HEIDI NAKAJIMA, MD, PHD, AND JOHN J. ROSOWSKI, PHD, WERE INVITED SPEAKERS AND GUESTS AT THE 100TH ANNIVERSARY OF THE UNIVERSITY HOSPITAL ZURICH DEPARTMENT OF OTORHINOLARYNGOLOGY, HEAD AND NECK SURGERY. BRIAN M. LIN, MD, WAS SELECTED BY THE AMERICAN JOURNAL OF EPIDEMIOLOGY (AJE) AND THE SOCIETY FOR EPIDEMIOLOGIC RESEARCH AS ONE OF TEN 2016 AJE REVIEWERS OF THE YEAR. BRIAN J. PARK, MD, MPH, FACS, WAS ACCEPTED AS A FELLOW OF THE AMERICAN COLLEGE OF SURGEONS. KATIE M. PHILLIPS, MD, RECEIVED THE JOHN J. CONLEY, MD RESIDENT RESEARCH AWARD FROM THE EASTERN SECTION OF THE TRIOLOGICAL SOCIETY. SIDHARTH V. PURAM, MD, PHD, RECEIVED THE RICHARD J. BELLUCCI, MD RESIDENT RESEARCH AWARD FROM THE EASTERN SECTION OF THE TRIOLOGICAL SOCIETY. GREGORY W. RANDOLPH, MD, FACS, FACE, CO-DIRECTED THE 2017 WORLD CONGRESS ON THYROID CANCER. ROSH SETHI, MD, MPH, GAVE A TALK AT THE 2ND WORLD CONGRESS ON ENDOSCOPIC EAR SURGERY IN BOLOGNA, ITALY. MARK G. SHRIME, MD, MPH, PHD, FACS, WAS THE RECIPIENT OF THE 2017 DAMON RUNYON CLINICAL INVESTIGATOR AWARD. GREGORY T. WHITMAN, MD, RELEASED HIS BOOK, DIZZINESS: WHY YOU FEEL DIZZY AND WHAT WILL HELP YOU FEEL BETTER. ANESTHESIOLOGY KATHRIN BOURDEU, MD- TEACHER OF THE YEAR AWARD LISA HAMMOND, MD- ANESTHESIA ROTATION EDUCATIONAL AWARD RADIOLOGY DR. PAUL CARUSO: PROMOTED TO ASSISTANT PROFESSOR; AWARD FOR BEST SCIENTIFIC PAPER ORAL PRESENTATION AT THE EUROPEAN CONGRESS OF RADIOLOGY IN VIENNA IN MARCH 2017 FOR OUR PRESENTATION ON DYNAMIC GADOLINIUM ENHANCED MR IMAGING OF THE TEMPOROMANDIBULAR JOINT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS DR. AMY JULIANO: PROMOTED TO ASSISTANT PROFESSOR DR. KATHERINE REINSHAGEN: AWARDED A CERTIFICATE OF MERIT FOR HER PRESENTATION AT ASHNR ENTITLED ENDOSCOPIC ENDONASAL SURGERY OF THE ORBIT: WHAT THE SURGEON WANTS TO KNOW; SELECTED FOR RSNA ADVANCED GRANT WRITING COURSE 2017-2018 DR. MARYBETH CUNNANE: PROMOTED TO ASSISTANT PROFESSOR DR. HILLARY KELLY: PARTNERS HEALTHCARE/MASSACHUSETTS GENERAL HOSPITAL-PARTNERS IN EXCELLENCE TEAM AWARD FOR CONTRAST REACTION SIMULATION TRAINING; MASSACHUSETTS GENERAL HOSPITAL DEPARTMENT OF RADIOLOGY- AWARD FOR EXCELLENCE IN RESIDENT EDUCATION (PRESENTED BY THE CLASS OF 2018) FORM 990, PART III, LINE 4C FACILITIES, EQUIPMENT AND TECHNOLOGY ENT MASS. EYE AND EAR, STONEHAM MOVED ITS OTOLARYNGOLOGY PRACTICE TO A BRAND NEW OFFICE SPACE AT 41 MONTVALE, WHICH OFFERS MORE CLINICAL EXAM ROOM SPACE. BEGAN RENOVATIONS ON THE DR. JOWETT/DR. HADLOCK SPEL LAB. MINOR ENHANCEMENTS WERE MADE TO THE MAIN CAMPUS HEARING AID CENTER (NEW RUGS, CHAIRS, AND PAINT). MINOR RENOVATIONS WERE MADE TO A LAB ON THE SIXTH FLOOR OF THE CONNECTOR BUILDING TO ACCOMMODATE NEW RECRUITS IN THE EATON-PEABODY LABORATORIES. ADDITIONAL EXAM ROOMS WERE ADDED TO THE OFFICE-BASED CLINIC AREA AT MASS. EYE AND EAR, QUINCY. ANESTHESIA 2 NIHON KOHDEN PATIENT MONITORS 2 NIHON KOHDEN MULTI-GAS ANALYZERS 7TH FLOOR ANESTHESIA CONFERENCE ROOM RENOVATION 7TH FLOOR ANESTHESIA SUITE RENOVATION RADIOLOGY CURRENT MRI WAS UPGRADED TO R5 SOFTWARE TO PROVIDE BETTER QUALITY AND COMMERCIAL ACCESS TO CLINICAL SCIENCE KEYS. NEW 2ND MRI HAS DPH AND DON APPROVAL. ON TRACK FOR SPRING 2018 STARTUP. VARIAN I5 RF DIGITAL UPGRADE TO FLUOROSCOPY MACHINE CT CONSOLE/SOFTWARE UPGRADE |
| COMMUNITY ENGAGEMENT | MICHAEL S. COHEN, MD, SENT EARMUFF-STYLE HEARING PROTECTION TO THE NEW ENGLAND PATRIOTS PLAYERS FOR THEIR KIDS TO WEAR DURING SUPER BOWL LI. HE ALSO HOSTED HIS ANNUAL HEARING CENTER FAMILY CARNIVAL, WHICH BRINGS DOZENS OF PATIENT FAMILIES TO MASS. EYE AND EAR FOR A DAY OF FUN. AARON K. REMENSCHNEIDER, MD, MPH, ALICIA M. QUESNEL, MD, AND RESEARCH FELLOW IMAN A. GHANAD ARE WORKING WITH THE MASSACHUSETTS COMMISSION FOR THE DEAF AND HARD OF HEARING ON CONTINUED SUPPORT FOR THE BOSTON MARATHON BOMBING VICTIMS. THEY HAVE ESTABLISHED A FORMAL COLLABORATION WITH THEM TO SERVE AND SUPPORT SURVIVORS, AND COLLECT CLINICAL OUTCOMES DATA ON PATIENTS WHO ARE LOCAL. THE VOICE AND SPEECH LABORATORY (VSL) WENT TO CONCORD-CARLISLE REGIONAL HIGH SCHOOL IN FOR A FULL-DAY PROGRAM GEARED TOWARD JUNIORS AND SENIORS, MANY OF WHOM ARE INTERESTED IN PURSUING CAREERS IN HEALTH SCIENCE. STAFF FROM MASS. EYE AND EAR, STONEHAM HELD A HOLIDAY TOY DRIVE FOR THE CHILDREN OF MALDEN. A NEW COLLABORATION BETWEEN MASS. EYE AND EAR AND SYMPHONY NEW HAMPSHIRE WAS ESTABLISHED. THE GOAL OF THIS PARTNERSHIP IS TO BRING MEDICALLY BASED MUSIC THERAPY PROGRAMS TO MASS. EYE AND EAR PATIENTS. OTOLARYNGOLOGY FACULTY AND RESIDENTS MET WITH HARVARD MEDICAL SCHOOL STUDENTS AT THE MASS. EYE AND EAR, LONGWOOD CAMPUS TO REVIEW BASIC HEAD AND NECK EXAM SKILLS. OPHTHALMOLOGY FACILITY/PROGRAMMATIC ESTABLISHED THE SIMMONS LESSELL FELLOWSHIP IN NEURO-OPHTHALMOLOGY ESTABLISHED THE THOMAS J. MADDEN FELLOWSHIP IN RETINA ESTABLISHED THE IRATY AWARD FOR RESEARCH IN RETINAL DISEASES ESTABLISHED THE MONTE J. WALLACE OPHTHALMOLOGY CHAIR IN RETINA NEW OPHTHALMOLOGY PATIENT CARE LOCATION OPENED IN MALDEN, MA - OFFERS COMPREHENSIVE OPHTHALMOLOGY, INCLUDING CATARACT SURGERY AND CONTACT LENSES, AS WELL AS EYE PLASTICS SERVICES - OPTOMETRY, GLAUCOMA AND CORNEA SERVICES IN THE FUTURE. FIRST MEDICAL CENTER IN NEW ENGLAND TO OFFER STATE-OF-THE-ART RETINAL SURGERY USING THE NGENUITY 3D VISUALIZATION SYSTEM OFFERING NEW FDA-APPROVED CORNEAL CROSS-LINKING PROCEDURE TO HALT PROGRESSION OF KERATOCONUS MASS. EYE AND EAR IS PARTICIPATING IN A NEW HARVARD MEDICAL SCHOOL FACULTY MENTORING LEADERSHIP CERTIFICATE PROGRAM THAT RUNS FROM NOVEMBER 8, 2017 THROUGH JUNE 13, 2018. THIS PROGRAM IS A MULTI-SESSION, PEER-LEARNING EXPERIENCE FOR MID-CAREER AND SENIOR FACULTY PHYSICIAN AND SCIENTIST MENTORS. THE GOAL FOR PARTICIPANTS OF THIS PROGRAM IS TO BECOME LEADERS IN MENTORING WHO WILL GO ON TO FACILITATE THE PROGRAM IN FUTURE YEARS, OR DEVELOP SIMILAR PROGRAMS AT THEIR OWN INSTITUTIONS. LAUNCHED THE RETINAL DISEASE INSTITUTE (RDI) CABINET-AN ADVISORY COUNCIL OF LEADERS IN RETINAL RESEARCH PHILANTHROPY WHO WILL WORK WITH MASS. EYE AND EAR/HARVARD OPHTHALMOLOGY RETINA LEADERS TO ACCELERATE CURES FOR RETINAL DISEASES. CABINET MEMBERS INCLUDE: JOAN MILLER, WYC GROUSBECK, CHARLES DE GUNZBURG, PETE ANKENY, CHRIS SNOOK, GEORGE YANCOPOULOS, TONY ADAMIS, AND GENE HILL. AS THE FIRST OF ITS KIND, THE RDI IS DESIGNED TO FOSTER PARTNERSHIPS BETWEEN MASS. EYE AND EAR/HARVARD OPHTHALMOLOGY FACULTY WORKING IN FIELDS RELATED TO RETINAL DISEASE AND THE WORLDS LEADING SCIENTISTS (BASIC BIOMEDICAL RESEARCHERS, CLINICIAN SCIENTISTS, ENGINEERS, AND CLINICIANS) WORKING OUTSIDE VISION RESEARCH. |
| FORM 990, PART VI, LINE 1A | THE INFIRMARY'S BYLAWS STATE THE FOLLOWING: THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. |
| FORM 990, PART VI, LINE 7A | THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION"). FORM 990, PART VI, LINE 7B THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY. FORM 990, PART VI, LINE 11B THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE MANAGER OF INVESTMENTS AND FOUNDATION ACCOUNTING. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING. FORM 990, PART VI, LINE 12C MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH. FORM 990, PART VI, LINE 15 THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS THE SALARIES OF THE CHIEFS AND VICE PRESIDENTS TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. COMPENSATION OF THOSE AT THE DIRECTOR LEVEL, INCLUDING THE DIRECTOR OF PROFESSIONAL REVENUE CYCLE, DIRECTOR OF FACILITIES PLANNING, AND CHIEF INFORMATION OFFICER IS REVIEWED AND APPROVED BY THE VICE PRESIDENT OF OPERATIONS. THE COMPENSATION COMMITTEE MEETING WAS HELD ON NOVEMBER 16, 2016. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE. |
| FORM 990, PART VI, LINE 19 | SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. |
| FORM 990, PART XI, LINE 9 | OTHER CHANGES IN NET ASSETS OR FUND BALANCES: ADJUSTMENT FOR PENSION AND POSTRETIREMENT RELATED CHANGES OTHER THAN NET PERIODIC PENSION COST: $4,668,500 |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (6 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| FDN OF THE MASS EYE & EAR INFIRMARYINC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 042785453 | SUPPORT | MA | 501(C)(3) | 10 | NA | false |
| MASSACHUSETTS EYE & EAR ASSOCIATES INC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 222658209 | PATIENT CARE | MA | 501(C)(3) | 10 | FOUNDATION | Yes (true) |
| CIRCLE COMPANY INC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 042801791 | TITLE HOLDING | MA | 501(C)(25) | N/A | FOUNDATION | Yes (true) |
| EMBANKMENT SERVICES INC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 043272965 | SUPPORT | MA | 501(C)(3) | 12 - TYPE 1 | FOUNDATION | Yes (true) |
| MASS EYE & EAR INFIRMARY PENSION PLAN | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 046067238 | PENSION PLAN | MA | 401(A) | N/A | NA | false |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||||||||||
| 20 STANIFORD STREET | BOSTON | MA | 02114 | 042129889 | RESEARCH | MA | 501(C)(3) | 7 | FOUNDATION | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (true) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (true) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (8 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| MASSACHUSETTS EYE & EAR PENSION PLAN | ||
| R | $9,905,341 | CASH |
| MASSACHUSETTS EYE & EAR ASSOCIATES | ||
| C | $2,133,819 | CASH |
| MASSACHUSETTS EYE & EAR ASSOCIATES | ||
| B | $14,251,289 | CASH |
| MASSACHUSETTS EYE & EAR ASSOCIATES | ||
| O | $25,308,186 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| B | $170,886 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| P | $298,042 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| P | $1,277,705 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| Q | $3,322,045 | CASH |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE R, PART V, LINE 15: | FormAndLineReferenceDesc |
| Explanation | CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY. | ExplanationTxt |